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ABSTRACT 
THE EXPRESSION AND LOCALIZATION OF CYTOPLAMIC 
POLYADENYLATION ELEMENT BINDING PROTEINS IN THE RETINA 
Xiangping Wang 
Nov 7,2008 
The current status of our knowledge of synaptic plasticity comes largely from studies of 
the hippocampus and the context of learning and memory. We remain largely ignorant of 
plasticity in other neural systems and contexts. The molecular basis of plasticity has 
recently been given new impetus due to the discovery of a local control mechanism 
which can regulate protein synthesis at stimulated synapses. This involves the use of 
cytoplasmic polyadenylation binding proteins (CPEBs) to regulate translation. The 
studies presented here attempt to show that these molecular components are present in 
the retina, a part of the central nervous system that has been seen, historically, as not 
plastic. 
Methods used: RT-PCR was used to determine the presence of mRNAs in tissue. In 
situ hybridization and immunofluorescence microscopy were used for localization of 
mRNAs and proteins respectively. Real-time PCR and Western blots were used for 
quantifications of mRNA and proteins during postnatal development. A bioinformatics 
program "CPE detector" and 3' RACE were used to identify potential mRNA targets for 
CPEB1 in the UTR databases and in the retina respectively. The PAT assay was used 
to determine the length of poly(A) tails for some potential mRNA targets. Data mining 
and sequence alignment were used to identify alternatively spliced isoforms of CPEB3. 
v 
Major Results: Our results demonstrated that CPEB1-4 were all present in the retina. 
The four CPEBs had similar distributions in the inner retina: predominantly in the retinal 
ganglion cell layer, and to a less extent, in the inner nuclear layer. However, CPEB1 had 
a laminar pattern in the inner plexiform layer, whereas CPEB3 was diffuse. The 
presence of CPEB1 was minimal in the outer plexiform layer in contrast to CPEB3. 
During postnatal development the levels of CPEB1, 3 and 4 were up-regulated; whereas 
the level of CPEB2 was constant. Potential mRNAs were identified as targets of 
CPEB1; some mRNA targets demonstrated elongated poly(A) tails at postnatal day7 or 
day12, consistent with the up-regulation of CPEB1 at these ages. Multiple isoforms, 
including a novel one, were identified for CPEB3. The alternative splicing of CPEB3 
could occur both in the UTRs and in the coding region. 
Major Conclusions/Significance: Our data demonstrated that more than one CPEB 
paralog is present in mouse retina. Potential mRNA targets for CPEB1 were present in 
the retina and gained elongated poly(A) tail in accordance with the up-regulation of 
CPEB1 during development. The increases of CPEB1, 3 and 4 during the development 
indicate a possible role of such CPEBs in synaptogenesis. Continuing up-regulation of 
CPEB1, 3 and 4 also indicate a role in the adult retina. Alternative splicing in the UTRs 
of CPEB3 indicates a complex regulation of CPEB3; multiple isoforms of CPEB3 protein 
indicate the functional complexity of CPEB3. The presence of CPEBs in the retina 
indicates the existence of a translational control system in the retina. 
Future studies: Future studies should focus on the identification of mRNA targets for 
each CPEB. Such potential targets can be validated using in vitro binding assays to 
confirm their interaction with CPEB proteins. CPEB can be knocked-down or 
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1. Synaptic plasticity 
CHAPTER I 
INTRODUCTION 
The old adage "use it or lose it" has been proven correct for many generations. It vividly 
defines the plasticity in a number of systems in our body, including the central nervous 
system (CNS). The CNS seems to be endowed with an extraordinary degree of plasticity, 
one of the important foundations for processes such as development, learning and 
memory (Silva 2003; Molnar et al. 2002). It is believed that strengthening of existing 
synapses and formation of new synaptic contacts underlies the formation and 
consolidation of memory; while the atrophy of synapses in the absence of reinforcement 
leads to forgetting (figure 1). 
Synaptic plasticity is defined as "the ability of synapses to change as circumstances 
require. They may alter function, such as increasing or decreasing their sensitivity; or 
they may increase or decrease in actual numbers. This phenomenon is thought to be 
the main source of the overall plasticity of nervous system pathways" (Dorland's 
Illustrated Medical Dictionary, 29th edition). Synaptic plastiCity portrays the ability of 
neurons to change their synaptic strength and efficacy of transmission in adaptation to 
input. Synaptic plastiCity can be embodied in several forms, including changes in the 
amount of neurotransmitters released from presynaptic terminals (Sala et al. 1998; 
Rosenmund et al. 1993), alteration in the composition and number of receptors lion 
channels on the postsynaptic membrane (Yashiro et al. 2005), re-remodeling of synaptic 
1 
Figure 1. Illustration of synaptic plasticity: memory and forgetting (LOscher et al. 2000) 
This is a simple illustration for the current understanding of the formation of "memory" 
with knowledge of current literature. When neurons receive high-frequency stimuli, a 
series of biochemical and morphological changes occur, which ultimately lead to 
strengthening of synaptic transmission and increase in the number of synapses. On the 
other hand, the reverse process - ''forgetting'' can occur: the synapses undergo 

















structure (Eliasieh et al. 2007), and an increase or decrease in the number of synapses 
(Tominaga-Yoshino et al. 2008). The manifestations of synaptic plasticity can be 
molecular, electrophysiological, morphological, and sometimes, behavioral. Some of the 
key synaptic molecules that have long been known for their involvement in synaptic 
plasticity are elaborated below: 
1) Glutamate receptors 
Glutamate is the most abundant excitatory neurotransmitter in the CNS. It is released 
from pre-synaptic cells following an appropriate stimulus, crosses the synaptic cleft, and 
binds to its receptors on post-synaptic cell membrane. Several types of glutamate 
receptors are present on the post-synaptic cell membrane. These receptors are 
categorized into two major classes: ionotropic glutamate receptors (iGluR), which are 
ion channels gated by the ligand, and metabotropic glutamate receptors (mGluR), which 
are coupled to secondary messenger pathways. The iGluRs are further divided into 
three classes, named for the glutamate antagonist they respond to: N-methyl-D-
aspartate receptor (NMDAR), a-amino-3-hydroxy-5-methyl-4-isoxazole propionate 
receptor (AMPAR), and kainate receptor (KAR) (figure 2). All of these types of glutamate 
receptors have been implicated in certain forms of synaptic plasticity (Kullmann and 
Lamsa 2008; Catania et al. 2007; MacDonald et al. 2006; Genoux and Montgomery 
2007; Kim et al. 2008; Isaac et al. 2007; Lau and Zukin 2007; Shepherd and Huganir 
2007; Bortolotto et al. 2005), with the best-established being NMDAR and AMPAR. 
4 
a) NMDAR 
NMDARs are multimeric protein complexes composed of subunits named NR1, NR2 and 
NR3, alternatively referred to as GRIN1-3 (figure 2a, 2b). Eight alternative splicing 
isoforms of NR1 have been identified with distinct tissue distributions. Four isoforms of 
NR2 (NR2A-D) are selectively expressed across various cell types, with NR2B being the 
predominant isoform in neurons. The NR2 subunit possesses the binding site for 
glutamate and determines the receptor's basic kinetic properties. However, the 
functional properties of NMDARs arise from the differential combination of NR1, NR2 
and NR3. A developmental NR2B-NR2A switch has been characterized in the CNS: 
NR2B is predominant in early stages, while NR2A gradually outnumbers NR2B in the 
later stages of development (Liu et al. 2004). The developmental switch from a NR2B to 
a NR2A dominant form is believed to be a modulator of synaptic plasticity (MacDonald et 
al. 2006) and NMDA neurotoxicity (Liu et al. 2007b; Zhou and Baudry 2006). The 
integration of NR3A or NR3B to NR1/NR2 subunits modifies the ion permeability of the 
receptor, and reduces NMDA-induced currents; co-assembly of NR3A or NR3B with 
NR1, in the absence of NR2, forms excitatory receptors that can be activated by glycine 
alone, but unaffected by glutamate or NMDA (Chatterton et al. 2002; Wada et al. 2006; 
Tong et al. 2008; Awobuluyi et al. 2007). All NMDA receptor subunits are 
transmembrane proteins. The intracellular domains of these subunits contain sites for 
several kinases such as protein kinase A (PKA), protein kinase C (PKC), 
Ca(2+)/calmodulin-dependent protein kinases (CaMKs), and tyrosine kinases that 
regulate the functions of the receptors (Wang et al. 2005; Wang et al. 2006). The 
intracellular domains also possess the binding sites for a series of structural, adaptor, or 
scaffolding proteins (Beresewicz 2007). 
5 
Figure 2. Classification and nomenclature of glutamate receptors 
a} Glutamate receptors are classified into two major classes: ionotropic receptors 
(iGluR) which are ion channels associated with receptors, and metabotropic 
receptors (mGluR) which are coupled to secondary messenger pathways. iGluR 
is divided into three types depending on the agonists they respond to: NMDA 
receptors (NMDAR), AMPA receptors (AMPAR), and kainate receptors (KAR). 
Each ionotropic receptor is multimeric. The types of subunits are listed below for 
each subtype. mGluR each is composed of one transmebrane protein subunit. 
The types of subunit for mGluR are also listed. 
b} Diagram of iGluR (modified from Kandel et ai, 1991). iGluRs are receptors 
associated with ion channels (top). Each iGluR is composed of multiple (4-5) 
subunits; each subunit is a transmembrane protein that crosses the membrane 
four times (bottom). 
c} Diagram of mGluR (modified from Kandel et ai, 1991). mGluRs are coupled to 
secondary messenger pathways (top). Each mGluR is formed from one 
polypeptide, which is a transmembrane protein that crosses the membrane 
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NMDARs (figure 3a) are Na+, K+ channels which are also highly permeable to Ca2+ 
(Mayer et al. 1987). NMDARs can be blocked by Mg2+ in a voltage-dependent way or by 
Zn2+ in a voltage-independent way (Westbrook and Mayer 1987). The activation of 
NMDARs requires the binding of glutamate and the co-agonist glycine, as well as 
membrane depolarization. Ca2+ influx via these receptors is believed to evoke 
glutamate-mediated synaptic plasticity (Baba et al. 2003; Kamiya et al. 2002; Christie et 
al. 1996; Cummings et al. 1996). A large amount of Ca2+ influx activates CaMKII, which 
ultimately increases the number of AMPAR on the post-synaptic membrane and 
elevates the efficacy of the synapses (Poncer et al. 2002). However, excessive Ca2+ 
influx can also lead to too much excitation (excitotoxicity) and neurotoxicity (Meldrum 
and Garthwaite 1990). 
b) AMPAR 
AMPARs are multimers composed of four distinct protein subunits, GluR1-4, 
alternatively named as GRIA1-4 (figure 2a, 2b). Alternative splicing isoforms of each 
subunit result in different functional properties such as the speed of desensitization and 
resensitization. The majority of AM PARs consist of a symmetric "dimer of the dimers", 
which are composed of GluR2 and either of GluR1 , GluR3, or GluR4 (Greger et al. 2007; 
Mayer 2005). GluR2-containing AMPARs are well-established key players in long-term 
synaptic plasticity (Isaac et al. 2007; Xia et al. 2007), although GluR2-absent AMPARs 
have also been demonstrated to playa role in synaptic plasticity as well (Meng et al. 
2003; Biou et al. 2008). 
AM PARs are ion channels permeable to Na+ and K+ (figure 3b). Their permeability to 
Ca2+ is determined by the presence or absence of GluR2. AM PARs that lack GluR2 are 
8 
Figure 3. Diagrams of two types of ionotropic glutamate receptors: NMDAR and AMPAR 
(modified from Kandel et al. 1991) 
a) NMDA receptor is selectively agonized by NMDA. The associated channels are 
permeable to Na+, K+, and highly permeable to Ca2+. NMDAR has selective 
binding sites for glutamate, glycine, Mg2+, Zn2+ and polyamines. The activation 
of NMDAR requires the binding of both glutamate and glycine. Mg2+ and Zn2+ 
inhibit NMDAR in a voltage-dependent and voltage-independent way, 
respectively. Polyamine is an important modulator of NMDAR. 
b) AMPA receptor is selectively agonized by AMPA. The associated channels are 
permeable to Na+ and K+. The permeability to Ca2+ is dependent on the 
subunit composition. GluR2-lacking AM PAR is permeable to Ca2+, while GluR2-
containing AMPAR is almost impermeable to Ca2+. Subunit composition also 
modulates the regulation of AMPAR. For example, GluR2-containing AMPAR 
can be blocked by polyamine in a voltage-dependent manner. 
9 
Figure 3 






well (figure 5), including a membrane associated form of the G protein Ras (Rosen et al. 
1994), Ca2+/calmodulin activated guanine exchange factors (GEFs), and cytoplasmic 
protein tyrosine kinase 2 (PTK2) (Orban et al. 1999). The activation of CaMKIl can also 
contribute to the activation of ERK2 by inhibiting an ERK inhibitor synaptic Ras-GTPase-
activating protein (synGAP) (Soderling et al. 2001). A recent study demonstrated that 
MAPK is required for phosphorylation of cytoplasmic polyadenylation binding protein 
(CPEB1) during meiosis in Xenopus oocyte, and MAPK directly phosphorylates CPEB1 
on four residues (T22, T164, 8184, 8248), but not on 8174 which is phosphorylated by 
aurora kinase (Keady et al. 2007). It is not known whether MAPK can activate CPEB1 in 
some form of synaptic plasticity in neurons. 
4) BDNF 
Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family and is 
known to have an essential role for neuronal survival and differentiation and neurite 
growth. BDNF also has an important role in memory formation and synaptic plasticity, 
particularly in glutamatergic neurons. The mature BDNF form preferably binds to and 
activates TrkB receptor, a member of the receptor tyrosine kinase family. Following 
secondary messenger signaling cascade, activated TrkB will induce the phosphorylation 
of glutamate receptor subunits thus affecting the glutamate receptor activity (figure 6) 
(Carvalho et al. 2008). In contrast, the unprocessed pro-form, proBDNF is coupled to 
p75 receptor and is possibly involved in cell death (Kenchappa et al. 2006). The mRNAs 
of BDNF and TrkB are localized to different subcelluler locations including synapses in 
the hippocampus and visual cortex. The accumulation and synaptic translocation of 
BDNF mRNA and proteins was elicited by depolarization stimuli via a pathway involving 
NMDAR, TrkB and an influx of Ca2+ (Tongiorgi et al. 2006). In the dentate gyrus of rats, 
21 
Figure 6. BNDFrrrkB signaling pathway and synaptic plasticity (Carvalho et al. 2008) 
BDNFrrrkB regulates the synaptic plasticity at glutamatergic synapses through pre- and 
postsynaptic targets. Pro-BDNF is secreted from both the pre- and post-synaptic 
membrane in an activity-regulated way. Mature BDNF generated by extracellular 
protease digestion of pro-BDNF acts on pre- and postsynaptic TrkB receptors, which is 
coupled to secondary messenger pathways. In presynaptic compartment, activated TrkB 
regulates glutamate release; whereas in postsynaptic space, activated TrkB elicits 
changes in glutamate receptor synthesis and phosphorylation, changes in gene 
transcription and local translation. These effects of BDNFrrrkB signaling pathway result 












Protein t synthesIs 
a brief infusion of BDNF induced the transcription and rapid dendrite trafficking of the 
immediate early gene activity-regulated cytoskeleton-associated protein (Arc), which is 
required for the local expansion of the actin cytoskeleton during late phase L TP (Soule 
et al. 2006; Bramham and Messaoudi 2005). BDNF signaling also regulates the 
localization and activation of the translational machinery, thus driving the local 
translation of synaptic mRNAs such as Arc and CamKlIa (Soule et al. 2006; Yin et al. 
2002; Bramham 2008; Aakalu et al. 2001). 
Neurotrophin is involved in the formation of neuronal connectivity at several levels. 
BDNF is involved in axonal and dentritic arborization and activity-dependent synaptic 
connectivity in retinal ganglion cells (Cohen-Cory and Lorn 2004), in the hippocampus 
and neocortex (Binder and Scharfman 2004). 
Several independent studies demonstrated that AMPAR can induce the up-regulation of 
BDNF in both Ca2+ -dependent and Ca2+ -independent manners. One study 
demonstrated that activation of a tyrosine kinase Lyn by AMPAR triggers the MAPK 
pathway and increases the expression of BDNF (Hayashi et al. 1999). 
Two transcript variants of BDNF are produced in the brain. Although both encode for the 
same protein, one has a short 3' untranslated region (3'UTR) and the other long 3' UTA. 
The short 3' UTR isoform is restricted to cell somata, whereas the long 3' UTR isoform 
can be located to synapses. Mutant animals with truncated long 3' UTR manifested 
impaired dendritic targeting of BNDF mRNA, deficits in dendritic pruning and 
enlargement, and selective impairment in long-term potentiation in the hippocampus (An 
et al. 2008). The mechanism by which long 3' UTR isoform of BDNF mRNA is localized 
and translated in the dendrites is yet to be determined. 
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5) Cytoskeletal, scaffolding, and adhesion molecules 
Synaptic remodeling requires a dynamic synaptic architecture. Post-synaptic density 
(PSD) is an electron-dense structure composed of hundreds of proteins, providing a 
scaffold for the delivery of membrane-bound receptors as well as a matrix for 
concentrated functional molecules such as kinases, phosphatases, and other key 
molecules of various signaling pathways involved in synaptic plasticity. Prominent 
members of the PSD include actin-based cytoskeleton proteins, scaffolding proteins, and 
adhesion molecules (figure 7) (Boeckers 2006). Cytoskeleton molecules including actin, 
spectrin, tubulin, microtubule-associated proteins have been isolated from the PSDs. 
Adhesion molecules such as cadherins are also present at synaptic junctions and playa 
critical role in synaptic plasticity (Huntley et al. 2002). 
The structure of the PSD is dynamic. Its major component, actin, can be a stable 
structural component or a dynamic filament. Drebrin, a side-binding protein of 
filamentous actin (F-actin), is located in spines and regulates the recruitment of actin and 
PSD-95 into filopodia, the precursor of dendritic spines (Takahashi et al. 2003; Mizui et 
al. 2005; Sekino et al. 2007). The neuronal cell adhesion molecule, N-cadherin, can be 
synthesized and recruited to the PSD during L TP in the hippocampus. 
Insertion of NR2B-containing NMDARs to the synaptic membrane is associated with a 
dynamic organization of the PSD and an actin-dependent increase in the size of 
dendritic spines (Mulholland and Chandler 2007). A key cytoskeleton molecule, the 
Protein Interacting with C-Kinase 1 (PICK1), was recently identified as a key regulator of 
AMPAR trafficking. PICK directly interacts with AM PAR and assists the removal of 





Figure 7. PSD - cytoskeletal, scaffolding, adhesion molecules and more 
(http://www.mcw.edu/FileLibrary/User/mschober/PSD_diagram.jpg) 
PSD forms the matrix and platform for key synaptic plasticity molecules to attach and 
function. PSD is composed of hudreds of different types of proteins, namely, 
cytoskeletal proteins, scaffolding proteins, adhesion molecules, and other synaptic 
plasticity-associated molecules. F-actin is one of the major components of PSD. 
CaMKlla is also highly enriched in PSD. Components of CPEB complexes have also 
been identified in PSD (ref). PSD provides anchor points for the enrichment of 
glutamate receptors AMPAR and NMDAR; it also provides a microenviroment for 




Most of the aforementioned synaptic plasticity molecules are enriched in synapses. A 
rapid regulation of their translation or synaptic localization needs to be in place in a 
temporally and spatially specific manner upon the arrival of stimuli. The synthesis and 
dynamic organization of these molecules is activity dependent, involving Ca2+ influx 
through activated glutamate receptors and voltage-gated calcium channels at the post-
synapse (Schubert and Dotti 2007; Certner and Matus 2005). For example, activation 
of NMDAR provides a regulation for the molecular conformational change of cadherin 
and leads to strengthened adhesion across the synaptic cleft. Nonetheless, the 
complete mechanisms of such regulation are yet to be delineated. 
2. Cytoplasmic polyadenylation and translational control 
Synaptic plasticity requires transcriptional and translational control for enduring changes 
in synaptic efficacy (Steward and Schuman 2001; Bading 2000). It needs to be 
demonstrated that the molecular processes underlying plasticity are temporally and 
spatially accurate as to when and where the stimulus was received. Recent reports 
indicate that local protein synthesis in dendrites under tight control may provide an 
essential mechanism for long term synaptic plasticity. Cytoplasmic polyadenylation may 
be able to provide a rational explanation of how this can be achieved. 
It is well established that all eukaryotic pre-mRNAs undergo polyadenylation in the 
nucleus before they are exported to the cytoplasm. The newly synthesized pre-mRNA is 
endonucleolytically cleaved at about 10 nucleotides upstream of the polyadenylation 
signal (PAS), a hexamer sequence in the 3' UTR. The poly(A) stretch is then added to 
the newly formed 3' end. The poly(A) tail and its bound proteins are important for 
termination of transcription, export of the mRNA from the nucleus, and protection of the 
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mRNA from degradation by exonuclease. Multiple variants of the PAS sequence have 
been identified in nature with different occurrences and distinct efficiencies for 
polyladenylation (table 1). 
Cytoplasmic polyadenylation was first identified in eggs and two-cell embryos (Clegg 
and Piko 1982; Clegg and Piko 1983a; Clegg and Piko 1983b; Wilt 1973), where little 
RNA transcription activity was detected. A serine protease tissue-type plasminogen 
activator (t-PA) was translated in a concerted manner in oocytes undergoing meiotic 
maturation. The mRNA of t-PA accumulates during oocyte growth until the oocyte is 
fully grown and arrested in meiosis. Resumption of meiosis triggered the polyadenylation 
of t-PA mRNA in the cytoplasm, which was immediately followed by translation and 
serves as a novel mechanism for translational regulation (Vassalli et al. 1989; Huarte et 
al. 1987). Timed expression of pre-stored mRNA was also observed during early 
embryonic development to initiate mitosis and in some circumstances, to dictate the 
polarity of the embyo. Such translational activation was accompanied by elongation of 
the poly(A) tails (Richter 1991; Simon et al. 1992). The same mechanism was later 
discovered to be employed by the hippocampus and several other parts of the central 
nervous system, for the acquisition and consolidation of memory, or for long-term 
synaptic plasticity. 
Both a PAS motif and a U-rich motif are required for cytoplasmic polyadenylation of 
mRNAs' (Fox et al. 1989; McGrew et al. 1989). This short U-rich sequence UUUUUAU 
was later dubbed the "cytoplasmic polyadenylation element" (CPE) (Fox et al. 1989). 
Several variants of CPE sequence have been identified (McGrew and Richter 1990; 
Simon et al. 1992) (table 2). CPE is often located upstream of the PAS within a distance 
of -10 nt to 100 nt, but in some instances overlaps with the PAS (figure 8). Many 
mRNAs have more than one CPE in their 3' UTA. The variant, the number of copies of 
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Table 1. Variants of polyadenylation signal (PAS) and their occurrence 
Data were adapted from (8eaudoing et al. 2000). "% sites" represented the 
occurrence of the hexamer within 50 nt upstream of potential poly(A) sites. A 
total number of 5647 putative poly(A) sites (generated by comparing human 
UTRs to EST sequences) were studied. 













Table 2. Variants of CPE sequence 
Sequences of CPE variants appeared in the literature are listed below (Fox et al. 1989; 







Figure 8. Features of mRNA targets for cytoplasmic polyadenylation 
The mRNA targets for cytoplasmic polyadenylation have two specific motifs in their 3' 
UTRs: cytoplasmic polyadenylation element (ePE) and polyadenylation signal (PAS). 
CPE is often located upstream of PAS, with a gap usually less than 100 nt. In some 
instances, ePE overlaps with PAS. Some mRNA targets have more than one ePE or 
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CPE and the distance to the PAS are widely variable for different mRNAs. Such 
variables could indicate the presence of modulators of the process of translational 
control. 
The CPE binding protein (CPEB) was first identified in 1990 in Xenopus oocytes 
(McGrew and Richter 1990; Paris et al. 1991). The term CPEB became interchangeable 
with CPEB1 later as more paralogs were identified. Invertebrate CPEB homologs have 
been documented for Drosophila (Chang et al. 1999), zebrafish (Bally-Cuif et al. 1998), 
C. e/egans (Luitjens et al. 2000), clam (Walker et al. 1999) and Aplysia (Si et al. 2003a). 
Studies on the mechanisms of CPEB-regulated translational control have been 
extensively focused on CPEB1. Although evidence suggested that similar machineries 
are employed in oocytes, early embryos, and CNS, the major discoveries were derived 
from work in oocytes, since oocyte maturation is a more facile and efficient model for 
CPEB1-regulated translational control. The complete mechanisms of CPEB1 regulated 
polyadenylation/translation is yet to be fully delineated. The current state of our 
knowledge is summarized below. 
1) CPEB 1-mediated translational control and its mechanisms 
Translation of maternal mRNAs is triggered by progesterone stimulation during oocyte 
maturation. Activation of progesterone receptors induces a cascade leading to the 
phosphorylation and activation of CPEB1, which is closely associated with the plasma 
membrane. One of the first mRNAs that undergo polyadenylation and translation is mos, 
which codes for a serine/threonine kinase. Mos protein in turn assists the 
polyadenylation-induced translation of cyclin B1 mRNA. Cyclin B1 together with its 
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bound cyclin-dependent kinase 1 (cdk1) will then be responsible for a series of events 
leading to oocyte maturation (Richter 2007). 
CPEB1 has a dual role: a translational activator and a translational inhibitor (figure 9). 
Under quiescent conditions, unphosphorylated CPEB1 binds to the 3' UTR of mRNA and 
represses translation. When cells respond to appropriate stimuli, the activation of 
CPEB1 via phosphorylation or the degradation of CPEB1 removes the repression and 
allows translation to initiate. The complete mechanism through which CPEB1 regulates 
polyadenylation is yet to be completely elucidated, but current knowledge indicates that 
it involves both the 3' and 5' end of the mRNAs. In the dormant state, an adaptor protein, 
maskin, interacts with both CPEB1 (which binds to CPE in the 3' UTR of the mRNA) and 
eukaryotic translation initiation factor 4E (eIF4E, which binds to 5' cap of the mRNA) 
(Stebbins-Boaz et al. 1999). This binding bends the mRNA molecule to bring its 3' and 
5' ends close together. The interaction of maskin to elF4E excludes eukaryotic 
translation initiation factor 4G (eIF4G) from binding to e1F4E. This blocks the assembly 
of the complete translational machinery. Phosphorylated CPEB is transformed into an 
activator which gains enhanced affinity for Cleavage and Polyadenylation Specific Factor 
(CPSF), which in turn recruits Poly(A) Polymerase (PAP) and initiates polyadenylation. 
The newly synthesized poly(A) tail is quickly bound and protected by Poly(A) Binding 
Protein (PABP) , which subsequently recruits translational initiation factor elF4G to 
displace maskin from elF4E (figure 9). This stabilized eIF4E-4G interaction enrolls the 
ribosome for initiation of translation. 
This model is supported by multiple studies on oocyte maturation. Maskin, CPSF, PAP 
and other components have been isolated from the cytoplasmic polyadenylation 
complex (Mendez et al. 2000; Barnard et al. 2004). 
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Figure 9. Diagrams of the mechanism for CPEB1-regulated translational control during 
oocyte maturation (modified from Groisman et al. 2002) 
a) Under dormant state, CPE-containing mRNAs are bound by unphosphorylated 
CPEB1, which also binds to maskin, an adaptor protein. Maskin in turn binds to 
eIF-4E and prevents the association of eIF-4E with eIF-4G. In this configuration, 
mRNA translation is repressed. The cleavage and polyadenylation specific factor 
(CPSF) mayor may not be associated with PAS prior to activation. 
b) When CPEB1 is phosphorylated in response to progesterone stimulus, it 
acquires increased affinity to CPSF. CPSF then binds to PAS and recruits 
polyadenylation polymerase (PAP), which results in the elongation of the poly(A) 
tail. Newly synthesized poly(A) tail is bound and protected by poly(A) binding 
proteins (PABP), which facilitates the recruitment of eIF-4G. eIF-4G displaces 
maskin from eIF-4E. The association of eIF-4E and eIF-4G recruits the ribosome 






2) Characterization of CPEB2, CPEB3, and CPEB4 
Besides the intensively-studied CPEB1, three additional paralogs of CPEB have been 
identified in rodents. Mouse CPEB2 was identified as abundant in post-meiotic haploid 
cells in testes and may have a role in spermatogenesis. Reverse transcription-
polymerase chain reaction (RT-PCR) demonstrated that CPEB2 was also expressed in 
cerebrum, cerebellum, salivary gland, thymus, liver, spleen, kidney, intestine, testis, and 
ovary (Kurihara et al. 2003). A systematic screen with PCR for CPEB genes in mouse 
brain revealed another two novel paralogs: CPEB3 and CPEB4. 
Sequence alignment demonstrated a less homologous N-terminus and a highly 
conserved C-terminus, among different paralogs and across species (figure 1 Oa). Two 
RNA recognition motifs (RRF) and a zinc finger region in the C terminal region are 
indispensible for RNA binding, as demonstrated by deletion experiments, and are highly 
conserved (Theis et al. 2003). Interestingly, rodent CPEB2, 3, and 4 share a much 
higher homology to one another than to CPEB1 (figure 10b). Cross-species 
comparisons demonstrated that mouse CPEB 1 is closer to Drosophila CPEB than to 
mouse CPEB2, and mouse CPEB2 is closer to Drosophila CPEB2 than to mouse 
CPEB1 (Theis et al. 2003). Such evidence strongly indicates that CPEB2, 3, and 4 
belong to a different subfamily which is rather distant from CPEB1. 
Multiple alternatively spliced isoforms have been identified for each of CPEB2, 3 and 4 
(Theis et al. 2003). The identified variable regions are the so-called B-region and C-
region (figure 11 a, 11 b). The significance of the C-region is unknown, but the B-region 
harbors the recognition sites for PKA, CaMKII, and p70S6 kinases (figure 11c). Unlike 
CPEB1, CPEB2-4 have no phosphorylation site for aurora kinase. But isoforms of 
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Figure 10. Comparison of mouse CPEB1-4 
a) The general structure of the CPEB proteins. The N terminus region is highly 
variable for different CPEBs, while the C-terminus is highly conserved. Two RNA 
binding motifs (RRM) together with a Zinc finger domain appear to be 
indispensable for RNA binding. 
b) Homology score of the full-length proteins and of the RNA-recognition motifs 
(RRM) between CPEB1-4 (Theis et al. 2003). In the overall structure, CPEB2-3, 
CPEB2-4, and CPEB3-4 demonstrate much higher identity (69.9,67.7, and 
56.8% respectively) than with CPEB1. Similarly, in the RNA recognition motifs, 
CPEB2-4 are almost identical (97-99%), whereas CPEB1 shares only 44.9% 
sequence with the other three. Comparisons were calculated using ClustalW. 
Scores represent the percentage of identical sequences. 
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Figure 11. Known alternatively spliced isoforms of CPEB2-4 (modified from Theis et al. 
2003) 
a) Schematic view of known mouse CPEB3 splice isoforms. (upper) CPEB3 
contains two amino acid stretches that are absent in some variants. The B 
region (hatched box) contains putative phosphorylation sites (filled circle) for 
PKC, CaMKlla and p70S6 kinases. The C region is upstream of the B region. 
The C and B regions can be spliced out individually or concurrently. 
b) Schematic view of known mouse CPEB4 spliced isoforms. For explanations, see 
a). Unlike CPEB3, the B region is not separated from C region in CPEB4. 
c) Sequence comparsion of variable regions Band C in mouse CPEB2, 3, and 4 
proteins. The B region is present in some variants of all three CPEBs. Putative 
phosphorylation sites for PKA, CaMKIl and p70S6 kinases are shown above the 
sequences, and the phosphorylaton site is indicated with an asterisk. The 
corresponding actual recognition sites are shaded. Note that the phosphorylated 
serine residue is not in the variable region, but the deletion of B region would 
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CPEB2-4 containing the B-region can be phosphorylated by PKA, CaMKIl and p70S6 
kinase (Theis et al. 2003). 
Different expression patterns have been characterized for CPEB1-4 in the brain. In the 
hippocampus, CPEB1, 2 and 4 mRNAs are all present in the CA1/CA31ayers and 
dentate gyrus. CPEB3 is barely detectable in these layers in the naIve state, but 
together with CPEB4 it is strongly up-regulated in kainaite-induced seizure. Notably, the 
CPEB3-4 isforms that were up-regulated after kainaite treatment were the ones 
containing the B-region (Theis et al. 2003) which possesses the phosphorylation site for 
PKA, CaMKIl and p70S6 kinases. Both CPEB3 and CPEB4 were strongly detected in 
post-synaptic density factions (Huang et al. 2006). In the cerebellum, both CPEB3 and 
CPEB4 were demonstrated in the granule cells. However, only CPEB3 appeared in the 
interneurons, and only CPEB4 appeared in the Pukinje cells. Additionally, CPEB3, but 
not CPEB4, appeared in the mitral cells of the olfactory bulb (Huang et al. 2006). 
Very little is known of the mechanisms by which CPEB2-4 operate. Based on the 
wide disparity in CPEB1 and CPEB2-4 sequences and differences in their tissue 
distribution, it is plausible that CPEB2-4 utilize distinct mechanisms from CPEB1. 
CPEB2-4 may be activated by different kinases such as PKA, CaMKlla, and p70S6 
while CPEB1 can be phosphorylated by aurora kinase. CPEB2-4 may have 
different substrate specificities. Huang and colleagues (Huang et al. 2006) 
demonstrated that CPEB3 recognizes a U-rich hairpin secondary structure in the 3' 
UTR of mRNAs (figure 12). The binding of CPEB3 to the hairpin motif and the 
binding of CPEB1 to the CPE motif is exclusive. CPEB3 but not CPEB1 protein 
binds to GluR2 mRNA both in vitro and in vivo. The application of CPEB3 siRNA in 
neurons resulted in an elevated level of GluR2 proteins (Huang et al. 2006). Similar 
to CPEB1, CPEB3 seemed to be a translational inhibitor of a reporter gene 
43 
Figure 12. RNA secondary structure for CPEB2-4 binding (Huang et al. 2006) 
a) A library of artificial RNA was generated from in vitro transcription. The 
oligonucleotide library composed of random 25-mers (variable sequence) flanked 
by constant sequences. The mixture was tested for binding to RBO of CPEB4 
using systematic evolution of ligands by exponential enrichment (SELEX) method. 
RNAs that had high binding affinity to the RBO of CPEB4 were listed. 
b) Predicted RNA secondary structure necessary for CPEB4 binding. A U-rich loop 
and a proximal stem upstream were both required. The nucleotides in the boxes 
indicated the ones protected by CPEB4. This model could be generalized to 




































construct in a naive stage, and transforms into an activator upon NMDAR 
stimulation. CPEB3-mediated translational control appeared to be independent of 
polyadenylation since it did not bind to CPSF nor did it require the PAS signal 
(Huang et al. 2006). 
3. CPEBs and synaptic plasticity 
Neurons are highly polarized cells that require differential distribution of proteins 
and mRNAs to different cellular compartments such as somata, axon and dendrites. 
A neuron can receive signals from thousands of cells. A dendrite that receives a 
signal is distinguished from many other dendrites that do not by establishing a "tag" 
of the stimulated synapse. This "tag" is composed of up-regulated proteins which 
will affect the way the synapse responds to stimuli in the future. Formation of such 
synaptic plasticity requires both temporally and spatially regulated translation at the 
synaptic sites. Many components of the protein synthesis machinery, including 
polysomes, CPEBs, and mRNAs are present in dendrites. This indicates that 
CPEB-mediated local translational control in response to synaptic activation could 
be one of the underlying mechanisms of synaptic plasticity (figure 13). 
1) CPEB1 and synaptic plasticity 
Intriguingly, the translational mechanisms employed by CPEB1 in oogenesis and early 
embryogenesis could be recapitulated in the brain. The CPEB that was most intensively 
studied for its role in synaptic plasticity is CPEB1. Localized translation at the synaptic 
sites is one of the essential underlying mechanisms for neuronal processes such as 
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Figure 13. Cytoplasmic polyadenylation and translation in neurons (Wells et al. 2000) 
Synaptic plasticity induces protein synthesis in neurons. CPEB is localized to synapses 
and enriched in the postsynaptic density (PSD) in the brain. Activation of NMDAR 
triggers the phosphorylation of CPEB and initiation of its target mRNAs (ref). This model 
is supported by the discovery that CPE-containing mRNA, CaMKlla, is enriched in PSD. 
Its polyadenylation and translation was up-regulated in the visual cortex of dark-reared 
animals when these animals were exposed to light (Wu et al. 1998). This process was 
blocked by antagonist of NMDAR or inhibitors of polyadenylation (Kirkwood et al. 1996; 
Wells et al. 1999). The mechanism of how NMDAR activates CPEB is yet to be 
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long-term memory and long-term synaptic plasticity. However, the mechanism by which 
translation is controlled and by which the proteins encoded modulate the prolonged 
changes biochemically is largely unknown. Some factors, including RNA-binding 
proteins and their target mRNAs at synaptic sites have been identified. For example, 
CPEB1 and Fragile-X Mental Retardation Proteins (FMRP) both have a function in the 
localization and translation of synaptic mRNAs. Because of the difficulty to manipulate 
primary neuron cultures such as low transfection rate for non-dividing cells, biochemical 
approaches to study the mechanisms are often carried out in more facile and efficient 
systems such as the oocyte. However, several techniques including the development of 
knockout animals, various viral delivery systems, small interference RNA (siRNA) 
knockdown techniques, have enabled some analysis of translational mechanisms in 
neurons. A surrogate system has also been employed by injecting brain-derived 
mRNAs into Xenopus oocytes to test their polyadenylation by CPEB1. 
CPEB1 is localized to dendritic layers of the hippocampus, the synapses in cultured 
neurons, and PSDs in adult brain. CPEB1 was phosphorylated upon NMDAR receptor 
activation, and triggered the polyadenylation and translation of CaMKlla mRNA at the 
synaptic sites (Huang et al. 2002; Wu et al. 1998). In CPEB1 knockout mice, several 
forms of electrophysiological features of Schaffer CA 1 neurons in response to single 
100-Hz stimulation and single theta burst stimulation were impaired, suggesting CPEB1 
plays a role in synaptic plasticity (Alarcon et al. 2004). Administration of CPEB siRNAs to 
the Aplysia neurons resulted in failure of the maintenance of long-term facilitation (Si et 
al. 2003a). 
Very few mRNAs are known CPEB1 targets in neurons. CaMKlla (Wu et al. 1998) and 
tPA (Shin et al. 2004) are two known mRNAs that undergo activity-dependent 
polyadenylation in hippocampal neurons. However, neither of these mRNAs appeared 
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to be responsible for the deficiency in plasticity observed in CPEB1 knockout mice (Silva 
et al. 1992b; Frey et al. 1996). This suggested the presence of other mRNAs in neurons 
whose translation is regulated by CPEB1. A recent study screening mouse brain 
mRNAs using the surrogate system identified six mRNAs (all have potential involvement 
in synaptic plasticity): AMPA receptor binding protein (ABP), a potassium channel ELK2, 
CaMKII~, microtubule-associated protein 2 (MAP2), and rat calmodulin (RCM3) mRNAs 
which became polyadenylated in response to synaptic activity (Ou and Richter 2005). 
The same study demonstrated that in synaptosomes treated with glutamate, the proteins 
levels of MAP2 and ABP increased significantly by 35% and 72%, respectively, 
compared to untreated control. 
CPEB 1 can be activated via several pathways. The induction of CPEB 1 phosphorylation 
and polyadenylation in the hippocampus can be elicited by NMOA, but not AMPA 
(Huang et al. 2002). Kainate has been demonstrated to trigger CaMKlla up-regUlation in 
the CA3 region of the hippocampus, an event that was blocked by a protein synthesis 
inhibitor cyclohexamide (Lee et al. 2003); kainate was also shown to stimulate 
polyadenylation (Ou and Richter 2005). It is likely that kainate-induced translation of 
CaMKlla occurred through CPEB1-mediated polyadenylation, which would indicate that 
CPEB 1 can be activated via kainate glutamate receptors. Another study observed that 
metabotropic glutamate activation triggered the polyadenylation of tPA mRNAs, 
suggesting that CPEB1 may be activated through metabotropic glutamate receptors 
(Shin et al. 2004). 
2) CPEB2-4 and synaptic plasticity 
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Although all four CPEBs have been identified in the nervous system, and the expression 
pattern has been characterized in some regions of the brain including the hippocampus, 
very little is known about the functions of CPEB2-4 in synaptic plasticity. CPEB3 is the 
second CPEB that has been under investigation in recent years. The mRNA of a key 
synaptic plasticity molecule, GluR2, can be bound by CPEB3. CPEB3 siRNA delivered 
to neurons led to elevated levels of GluR2 protein (Huang et al. 2006). 
Although some aspects of the involvement of CPEB1 in synaptic plasticity have been 
revealed, such as the regulation of CaMKlIa translation, little is known about the roles of 
CPEB2-4 in synaptic plasticity. Sequence alignment demonstrated a close proximity of 
CPEB2-4 in the family tree but a wide distance to CPEB1. CPEB2-4Iack the 
phosphorylation site for aurora kinase, a known activator for CPEB1 (Theis et al. 2003). 
But some alternatively spliced isoforms of CPEB2-4 have the B-region which is absent in 
CPEB1. The B-region possesses phosphorylation sites for PKA, CaMKlla, and p70S6 
kinases (Theis et al. 2003). These data indicated that CPEB2-4 may be activated via 
distinct pathways than CPEB1. In kainate-induced seizures in the hippocampus, the 
expression of CPEB3 and CPEB4, but not CPEB1, were dramatically increased (Huang 
et al. 2006), suggesting that CPEB3 and 4 are responsible for different forms of plasticity 
compared to CPEB1. A U-rich loop secondary structure in the 3' UTR of mRNAs, but 
not CPE, is required for CPEB2-4 binding (Huang et al. 2006), indicating CPEB2-4 have 
discrete set of mRNA targets distinct from CPEB1. However, functional compensation 
or redundancy between CPEB1 and CPEB2-4 is not ruled out, since LTP was not 
completely eradicated in CPEB1 knockout mice. What is noteworthy is that CPEB3 may 
form a positive or negative feedback loop for CPEB1, since its mRNA contains two CPE 
sites in the 3' UTA. 
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4. ePEB and RNA localization 
ePEB regulated translation of ePE-containing mRNAs is a temporally or spatially tightly 
controlled process. It is the common underlying foundation for oogenesis, 
embryogenesis and would be a requirement for the demonstration of specificity of 
synaptic plasticity. Both ePEB protein and its target mRNAs need to be localized to the 
proper location for the local control of translation. The cis-element ePE in the 3' UTR of 
mRNA molecules and the RNA-binding protein ePEB have been demonstrated in the 
transport of such mRNAs. 
1) ePEB and mRNA localization in Drosophila 
Localized maternal mRNA is essential for the establishment of polarity in early 
development. The Drosophila CPEB homolog, orb, is required at multiple steps of 
oogenesis and is important for the establishment of both dorsal-ventral (OV) and 
anterior-posterior (AP) poles in early embryo development. Several maternal mRNAs are 
known to be involved in the establishment of these polarities, such as bicoid (St 
Johnston and Nusslein-Volhard 1992), nanos, oskar (Ephrussi et al 1991), fs(1 )K1 0 and 
gurken (Haenlin et al. 1987, Cheung et al. 1992; Neuman-Silberberg and Schupbach 
1993). Under normal development these mRNAs are localized to a specific pole and are 
translated upon fertilization to generate gradient proteins which then direct the 
localization or expression of other genes to generate the polarity of the developing 
embryo. Localization of such mRNAs to specific locations requires both cis-elements 
and trans-elements. The cis-elements are specific "tags" in the mRNA sequence that 
mark the mRNA for localization. They are specific motifs to be recognized and bound by 
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RNA binding proteins. The trans-elements are RNA-binding proteins that transport and 
anchor the mRNA molecules to proper locations. Such trans-elements include general 
cytoskeleton proteins such as microtubules (Pokrywka and Stephenson 1991; Theurkauf 
et. al 1992) and staufen protein (Ferrandon et al. 1994; Micklem et al. 2000). The 
Drosophila CPEB homolog, orb, is involved in mRNA localization (Lantz 1992), with a 
complex localization pattern evident during oogenesis (Bally-Cuif et al. 1998). Several 
orb site mutations in Drosophila oocytes caused stalled development in the 8-cell cyst or 
16-cell cyst stage. A less severe mutation did not stop the development but did cause 
abnormal distribution of mRNAs along both AP and DV poles. Maternal mRNAs such as 
oska, gurken and 1s(1 )K1 0 are misplaced in the orb mutant (Christerson and Mckearin 
1994; Lantz et al. 1994). 
2) CPEB and the mRNA transportation in Xenopus oocytes 
During Xenopus oocyte maturation, mRNAs coding for c-mos, cdk2, several cyclins 
among others, undergo cytoplasmic polyadenylation and translational up-regulation. 
Several mRNAs are regionally concentrated in Xenopus oocyte (Schnapp et aI., 1997). 
CPEB proteins and maskin are moderately concentrated in the animal pole in Xenopus 
oocytes, and became more concentrated in eggs and early embryos due to the dominant 
protein degradation in the vegetal pole. Both proteins colocalized with a-tubulin on the 
centrosomes and mitotic spindles in the animal pole. Two mRNAs, xub3 and cYciin B1, 
both containing CPE motifs in the 3' UTR, are localized with or near CPEB on 
centrosomes or spindles (Groinsman et al. 2000). While the importance of xbub3 is not 
known, cyclin B1 is important for cell cycle. Injection of CPEB antibody, mutant CPEB 
with disrupted phosphorylation site, or a polyadenylation inhibitor cordycepin (3'-dATP), 
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blocked cytoplasmic polyadenylation-induced translation of cyclin B1 (Groinsman et al. 
2000). A CPEB mutation that does not bind to the centromere in vivo disrupted the 
localization of cyclin B1 mRNA. Such findings indicated a role of CPEB for the 
localization of CPE-containing mRNAs, consistent with the observation in Drosophila 
and zebrafish. 
3) CPEB and mRNA localization in the CNS 
In neurons, local translational regulation of synaptically enriched mRNAs such as the 
activity-dependent cytoskeleton protein Arc (Steward et al. 1998), MAP2, CaMKlla 
(Roberts et al. 1998), BDNF, and TrkB (Tongiorgi et al. 1996) is implicated in synaptic 
plasticity. The mechanism for the localization of such mRNAs to synapses is yet to be 
delineated. Recent evidence indicates that the cis-element CPE is sufficient to direct 
CPE-containing mRNAs to the dendrites, and the process of such localization is 
facilitated by CPEB. CPEB, together with its adaptor protein maskin, forms RNA-
containing particles that were transported to dendrites in a microtubule-dependent 
manner, suggesting that these mRNAs were transported in a translationally dormant 
form. Such transportation particles also contained the molecular motor dynein and 
kinesin. The transport of dendritically localized mRNAs was enhanced in neurons 
overexpressing CPEB, but inhibited in neurons expressing mutated CPEB or in CPEB 
knockout mice (Huang et al. 2003). 
5. Synaptic plasticity in the neural retina 
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The neural retina is located at the back of the eye (figure 14). It receives light stimulus 
and sends the signal to the upper levels of the visual system. The retinal circuitry is 
composed of primarily vertical pathways with inhibitory modulations from lateral 
pathways (figure 15): Light projects on the light-sensitive photoreceptor cells in the outer 
nuclear layer (ONL), which will transmit signal to the interneurons- bipolar cells in the 
inner nuclear layer (INL), which will then relay signal to the ganglion cells in the retinal 
ganglion cell layer (RGC). Retinal ganglion cells ultimately collect the signal and project 
it to higher center of the visual system. The excitatory neurotransmitter glutamate is the 
predominant neurotransmitter employed in the vertical pathway. 
In addition to the vertical pathway, there are two tiers of lateral pathways: Horizontal 
cells in the outer boundary of the INL integrate signals from multiple photoreceptor cells 
and modulate them as necessary before sending them on to bipolar cells. Amacrine 
cells in the inner boundary of the INL integrate and modulate signals from bipolar cells 
before sending them on to the retinal ganglion cells. The predominant neurotransmitter 
used in the lateral pathways is gamma-aminobutyric acid (GABA). 
Synaptic connections of the retina are located within well-characterized laminar 
structures: the outer plexiform layer (OPL) and the inner plexiform layer (IPL). The OPL 
is composed of synaptic connections between photo receptors, bipolar cells and 
horizontal cells. The I PL is composed of synaptic connections between bipolar cells, 
ganglion cells and amacrine cells. 
SynaptiC plasticity has long been recognized at higher levels of CNS, such as the 
cerebral cortex (Cheetham et al. 2008), the hippocampus (Nicoll and Schmitz 2005), and 
the cerebellum (Jorntell and Hansel 2006). It has also been depicted at higher levels of 
the visual system (Karmarkar and Dan 2006). Neuroscientists have long thought that 
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Figure 14. Diagram of the eye (www.nei.nih.gov/health/eyediagram/eyeimages2.asp) 
The diagram shows the location of the retina within the eye. The retina is the innermost 
layer at the back of the eye. Light enters the cornea, passes through the lens and is 
projected onto the retina, where it is converted into electrochemical signals and sent 







Figure 15. Diagram of the retina (Kandel et al. 2000) 
This figure illustrates the laminar structure, the major cell types, and the vertical and 
horizontal pathways of the retina. The retina has a unique laminar structure. From the 
outer part of the eye to inner part of the eye, lie outer nuclear layer, outer plexiform layer, 
inner nuclear layer, inner plexiform layer, and ganglion cell layer. Light stimulus enters 
the eye and projects on photoreceptors (rods or cones). Photoreceptors then send 
signals via vertical pathway to bipolar cells, and to ganglion cells. The vertical pathway 
is modulated by horizontal pathway from horizontal cells at the outer plexiform layer and 
from amacrine cells in the inner plexiform layer. The ganglion cells send output to higher 
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the neural retina lacks the property of plasticity. However, recent studies have provided 
several lines of evidence, including morphological, molecular and electrophysiological 
observations, which support the notion that synaptic plasticity is present in the retina. 
For example, synaptic remodeling in the outer plexiform layer has been observed as a 
result of photoreceptor loss in transgenic, diseased, or ageing retina. An increase in the 
number of synaptic ribbons per synapse, together with an increase in the number of 
processes originated from bipolar neurons participating in these synapses, were 
observed in mice with degenerated photoreceptors (Jansen et al. 1997). Ecotopic 
synaptogenesis - rod bipolar cell terminals extended into the outer nuclear layer to 
reconnect with degenerated rod terminals- has been observed in rod-specific mutation 
models (Peng et al. 2000; Peng et al. 2003), in retina of epilepsy patients treated with a 
GABA-transaminase inhibitor vigabatrin (Wang et al. 2008), in retinal of AMD patients 
(Sullivan et al. 2007), and in normal ageing retina (Eliasieh et al. 2007). 
Dark-rearing suppressed the maturational pruning in the inner plexiform layer, of 
bistratified dentrites into the characteristic monostratified pattern which normally occurs 
after eye-opening (Tian and Copenhagen 2001; Tian and Copenhagen 2003). In addition, 
visual deprivation elevated the expression of several important synaptic components, 
such as CaMKII, GluR1 and NR1 in the retinal ganglion cells (Xue et al. 2001; Xue and 
Cooper 2001). Light responsiveness measured as electroretinogram (ERG) and 
oscillatory potentials (OP) were inhibited in both young and adult dark-reared animals 
(Vistamehr and Tian 2004). Even under normal diurnal environment, AMPARs undergo 
rapid recycling via endocytosis and exocytosis in the retinal ganglion neurons (Xia et al. 
2006), and such rapid cycling is primarily restricted to GluR2-containing AMPARs (Xia et 
al. 2007), which playa pivotal role in long-term synaptic plasticity (Tanaka et al. 2000; 
Isaac et al. 2007). Together, these data support the notion that plasticity is a 
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phenomenon that is a characteristic of retinal synapses as it is for synapses in other 
parts of the CNS. 
Synaptogenesis is a postnatally ongoing process in the rodent retina. Rodent retina is 
premature and the synaptic structure is not well-established at the time of birth. It is not 
until approximately eye-opening stage, which is about 14 days postnatally in mouse that 
the synaptic structure in the plexiform layers becomes functional (Tian and Copenhagen 
2001). Synaptogenesis in the inner plexiform layer (IPL) starts at day 3 and continues 
until before eye-opening, when the rate of synaptogenesis in the INL drops precipitously 
(Fisher 1979b; Fisher 1979a). Robust glutamatergic synaptic formation occurs in the 
second postanatal week, and synaptic sublamina becomes visible in the inner plexiform 
layer on postnatal day 12 (P12) (Sherry et al. 2003). Synaptic connections in OPL begin 
to develop on postnatal day 3 (P3) and are well established by P12, when the first light 
response was recorded as ERG (Rich et al. 1997). A diagram illustrating the 
morphological maturation of synaptic structures between different types of cells is 
presented in figure 16. 
6. CPEBs and CPE-containing mRNAs in the retina 
Several findings have indicated the presence of cytoplasmic polyadenylation in the retina. 
Of the four mouse CPEBs (CPEB 1-4) characterized to date (Gebauer and Richter 1996; 
Theis et al. 2003; Kurihara et al. 2003), one (CPEB1) has been shown to be present in 
the mouse retina of both wildtype and rod-ablated model (rdta) mice (Liu et al. 2000). 
Multiple studies have shown that the mRNA of a key molecule for synaptic plasticity, 
CaMKlla, which has two CPE motifs in its 3' UTR, is present in the retina (Liu and 
Cooper 1996; Cooper et al. 1995; Terashima et al. 1994), and could possibly be involved 
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Figure 16. Timeframe of synaptogenesis in mouse retina (modified from Olney 1968) 
Time table of morphological maturation for the synapses in mouse retina. Heavy lines 
indicated periods of accelerated development; broken lines indicated periods of relative 
quiescence or slow development. R-photoreceptors; H-horizontal cells; BP-bipolar cells; 
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in the dendritic development and/or plasticity (Okada et al. 1999; Weiler et al. 1996; 
Weiler et al. 1995). The early growth response factor-1 (EGR1), a member of zinc-finger 
transcription factor family, is expressed in synapses across the retina. The longer form 
of its two alternative spliced mRNA isoforms possesses a CPE in its 3' UTR, and 
therefore can translate rapidly upon excitatory stimuli such as light and NMDAR 
activation (Simon et al. 2004). A key synaptic plasticity molecule GluR2 contributes to 
the physiological property of AMPARs and is present in neurons in the retina (Hughes et 
al. 1992; Hamassaki-Britto et al. 1993). It is unknown whether the other CPEBs are also 
expressed in the retina and this lack of knowledge will hamper further characterization of 
any putative retinal synaptic plasticity. 
In this study, the presence, the localization and the expression patterns of all four 
CPEBs in the mouse retina were investigated. The developmental appearance of all 
four CPEBs during postnatal development was characterized. Potential mRNA targets 
for CPEB1, whose cis-acting element is well established, were studied. The alternative 
spliced isoforms of CPEB3 associated with the retina was explored. 
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CHAPTER II 
HYPOTHESIS AND SPECIFIC AIMS 
The retina is a favorite model for the study of the central nervous systems because it is 
an accessible part of the brain (Dowling 1987) with an endowed fine laminar structure 
and easy access for molecular and electrophysiological manipulations. The well-defined 
cellular types and neuronal pathways between distinct cell types could make the retina 
an invaluable tool for neurobiological studies. 
Synaptic plasticity has long been appreciated at higher levels of the visual system. The 
neural retina as part of the central nervous system contains the same kind of synaptic 
machinery as other regions of the brain (Dowling 1987). This prompted the questions 
regarding the presence of synaptic plasticity in the retina. Several lines of evidence 
demonstrated that the retina is capable of remodeling its synaptic structures. The 
synaptic structures of the IPL of mouse retina are disoriented at birth, but become well-
established multiple sublaminae before eye-opening. Such a process was retarded in 
animals subjected to dark-rearing (Tian and Copenhagen 2001). The fine structures of 
the OPL synaptic connections have also been demonstrated to undergo profound 
remodeling under certain conditions. Morphological alterations have been observed in 
rod bipolar cell terminals in ageing or diseased models. Light responsiveness measured 
as ERGs and OPs were inhibited in both young and adult dark-reared animals 
(Vistamehr and Tian 2004). The NMDAR-associated currents were down-regulated in 
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concurrence with eye-opening in na'ive animal, but such an alteration was impeded in 
dark-reared animals. These manifestations in morphology and electrophysiology 
indicated that the retina has some degree of plasticity. 
Some key molecules involved in activity-dependent synaptic plasticity have been 
identified in the retina. Cytoplasmic polyadenylation, the underlying mechanism for 
activity-dependent long-term plasticity in the hippocampus and the visual cortex, has 
been indicated to be present in the retina. A previous study observed CPEB1 in the 
retina of both wildtype mice and rdta mice (Liu et al. 2000). Other molecules implicated 
in synaptic plasticity such as CaMKlla and GluR2 mRNA, which can be recognized by 
CPEB1 and CPEB3 respectively, are enriched in the synapses of the retina. EGR1, an 
early gene that encode for a transcriptional factor in long-term synaptic plasticity, is 
present in the retina with two alternative splicing isoforms. The translation of the longer 
version of EGR1 transcript which has CPE in its 3' UTR is regulated by excitatory stimuli 
such as light and NMDAR activation in the retina (Simon et al. 2004). If the elements 
which endow synapses with the property of plasticity can be found in the retina, it would 
enhance its reputation as a more accessible model for such studies. 
Based on the observations of previous studies, I hypothesize that more than one paralog 
of CPEB is present in the retina. 
Aim1: To determine the expression pattern of CPEB1 in the retina. 
Specifically, this aim will investigate the types of cells expressing CPEB1; the regulation 
of CPEB1 during the development, and the potential mRNA targets of CPEB1 in the 
retina. The localization of CPEB1 will be explored with in situ hybridization at the mRNA 
level and immunofluorescence at the protein level. The temporal appearance of CPEB1 
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during post-natal development will be assessed with the aid of real-time PCR for mRNA 
and with Western blots and immunocytochemistry for protein. The potential targets of 
CPEB 1 will be identified from nucleotide and protein databases using a bioinformatics 
tool in combination with rapid amplification of cDNA ends (RACE)-PCR. Several 
candidates will be assayed with the aid of the polyadenylaiton test (PAT) to demonstrate 
their status of polyadenylation in the paradigms of a light-dark period as well as during 
postnatal development. 
Aim 2: To characterize the expression of CPEB3 in the retina. 
Specifically, this aim will explore isoforms of CPEB3 mRNA and protein; the types of 
cells that express CPEB3, and the regulation of CPEB3 during postnatal development. 
Bioinformatic analysis will be used to identify current known CPEB3 transcript variants 
and protein isoforms. RT -PCR will be used to characterize the tissue distribution of each 
isoform in the retina and in multiple other tissues. In situ hybridization and 
immunofluorescence microscopy will be used to determine the localization of CPEB3 
mRNA and proteins, respectively. Real-time PCR and Western blots will be used to 
investigate the regulation of CPEB3 transcripts and proteins during post-natal 
development. 
Aim 3: To compare CPEB1-4 in the retina. 
Specifically, this aim will investigate the types of cells that express mRNAs for CPEB1-4; 
the temporal appearance of CPEB1-4 during postnatal development, and the relative 
expression levels of CPEB1-4 in the retina. Comparison of the localization of four 
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CPEBs in the retina will be performed with the aid of in situ hybridization. Comparison of 
the appearance of all four CPEBs during post-natal development will be performed with 
the aid of real-time PCR. Cross-comparison quantification with the aid of real-time PCR 
data will be used to assess the relative abundance of CPEB 1-4. 
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CHAPTER III 
MATERIALS AND METHODS 
1. Animal handling and tissue preparation 
All animal experiments were carried out in compliance with the National Institutes of 
Health Guide for the Care and Use of Laboratory Animals, the University of Louisville 
Institutional Animal Care and Use Committee (IACUC) animal care regulations, as well 
as the Association for Research in Vision and Ophthalmology (ARVO) statement for the 
use of animals in ophthalmic and vision research. 
C57/BL6 mice were used for this study (Charles River Laboratories, Davis, CA). Mice at 
the age of postnatal day 1, 7, 12, 14, 16, 30, and 60 were used for developmental 
studies. All the pups younger than 21 days old were raised together with their lactating 
mothers. All animals were housed in normal diurnal cycles of 12-hour lighV12-hour dark 
unless otherwisely specified. Each experimental group was composed of at least 5-6 
animals. 
For tissue collection, mice were euthanized with CO2 followed by cervical dislocation. 
For RNA and protein extraction, the eyes were removed; retinas were quickly dissected 
and immediately frozen on dry ice before proceeding for extraction. Similar procedures 
were followed when other tissues were collected for RNA extraction. For in situ 
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hybridization and immunohistochemistry, the eyes were removed and immediately fixed 
in 4% paraformaldehyde for 12 hours at 4°C. The eyes were then transferred to PBS 
buffer with 30% sucrose for dehydration for two weeks at 4°C. Snap-freezing technique 
was used for the embedment: A stainless isopentane container was placed on dry ice. 
Immediately before embedding, crushed dry ice was scattered in the isopentane until no 
bubbles were generated from the mixture, an indication that the temperature reached 
below -70DC. The retina placed in tissue mounting medium in a mold was then floated 
on the fluid (by holding the mold with a pair of forceps). Make sure that the mold was not 
submerged in the isopentane/dry ice mixture. The embedding process should take 
several seconds. The mounted tissue was then cut on a cryostat the same day or frozen 
air-tight at -SO°C for future processing. 
2. Bioinformatic analysis - mRNA targets for CPEB1 
In order to identify additional mRNAs potentially regulated by CPEB1, a bioinformatics 
program, "CPE Motif Detector" was developed in collaboration with Dr. Eric Rouchka. 
This program took into account the CPE motif, the presence of poly(A) signal sequence, 
and a distance measure (spacer nucleotides) between those two. A database of 3' UTR 
sequences was downloaded from UTResource (www.ba.itb.cnr.itlUTR/) and these 3' 
UTRs were searched. Initial screens of CPE elements were found by looking for the 
pattern TTTTTATT upstream of the poly-A signal AATAAA with a spacer sequence 
between the two. For instance, if the expected spacer is between 50 and 100 bases, the 
sequence can be searched using the Perl regular expression: 
$seq =- "tttttatt(altlclgln){50,1 OO}aataaa") 
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In order to search for two or more CPE sites, the CPE motif was expanded to search for: 
$seq =- "ttttt(alg)tt(altlclgln){1 ,}ttttt(alg)tt(altlclgln){1 ,}aataaa" 
This pattern will allow alternative CPE motifs. Note, however, that this pattern does not 
limit the range of the spacer between the two motifs, or between the second motif and 
the poly-A signal. 
3. Data mining -isoforms of CPEB3 
UniGene database from NCBI databases (http://www.ncbLnlm.nih.gov) was used for the 
identification of CPEB3 transcript variants. NCBI and Swiss-ProtlTrEMBL 
(http://expasy.org/sprot/) databases were used for the identification of CPEB3 protein 
isoforms. Sequence alignments of transcripts and of proteins were carried out using 
ClustalW 2.0.5 (http://www.ebLac.ukITools/clustalw2/); sequence alignments of 
transcripts with proteins were carried out using Vector NTI (Invitrogen, Carlsbad, CA); 
sequence alignments of cDNAs with genomic DNA was carried out using UCSC mouse 
genome Blat (http://genome.ucsc.edu). 
4. Isolation of RNAs 
Frozen retina was homogenized rapidly using PowerGen 250 homogenizer (Fisher 
Scientific, Pittsburgh, PA). Total RNA was extracted using RNeasy mini kit (Qiagen, 
Valencia, CA) following the manufacturer's instructions. Briefly, tissue was 
homogenized for 10 seconds in an appropriate volume of lysis buffer, followed by chilling 
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on ice. This was repeated twice at 10 seconds each time. The lysate was then 
centrifuged at 14,000xg, and the supernatant was collected and transferred to a new 
tube. One volume of 70% ethanol was added and the mixture was quickly loaded to 
RNeasy spin columns and centrifuged briefly. The columns were then washed with 
buffer RW1 once, with buffer RPE twice, before RNA was eluted in RNase-free H20. 
RNA concentration was determined using a BioPhotometer (Eppendorf, Westbury, NY). 
The concentration of RNA was adjusted by dilution to an A260 within the range 0.1-1.0. 
The concentrations of RNA samples were calculated based on the absorbance at 260nm 
using the following equation: 
RNA concentration (\1g/ml) = A260 x 40 x dilution factor 
5\11 of each RNA sample was electrophoresed on an agarose gel. The quality of RNA 
was determined from the ratio of 288/188 on agarose gel. RNA was frozen in -80·C for 
long term storage. 
5. Regular RT-PCR 
0.2\1g of total RNA was used for every 20\11 RT reactions. Omniscript reverse 
transcriptase (Qiagen, Valencia, CA) and oligo-dT 15-mers were used to enable efficient 
and sensitive reverse transcription. Components were assembled using conditions 
according to the manufacturer's suggestions; reactions were incubated for 60 min at 
37°C. 
1\11 of the cDNA was used for subsequent PCR. Hot8tarTaq DNA polymerase (Qiagen, 
Valencia, CA) was used for robust and specific amplification. Components were 
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assembled according to manufacturer's instructions. The following settings of the 
thermocycler were used: 
Initial activation step: 95°C, 15min. 
Amplification: 
40 cycles of: 94°C,30sec; 
55-60°C (approximately 5°C below Tm of primers), 30sec; 
72°C,1min. 
Final extension: 72°C, 10min. 
Exon-exon spanning, gene-specific primers (lOT, Coralville, IA) were used for the 
identification of CPEB1-4 and the positive control l3-actin transcripts (table 3). Exon-
exon spanning, transcript specific primers were used for the identification of CPEB3 
alternatively spliced variants (table 4). The Resultant PCR products were visualized on 
1 % agarose gel and photographed. Each specific band was purified from the gel and 
sequenced for confirmation of its identity. 
6. 3' RACE RT-PCR 
Total RNA from mouse retina was used for 3' RACE RT-PCR. FirstChoice RLM-RACE 
kit (Ambion, Austin, TX) was used for the amplification. An overview of the procedure is 
illustrated in figure 17. Briefly, first strand cONA was synthesized from the retinal RNA 
using the 3' RACE Adapter primer - an oligo-dT primer with an anchor sequence at the 
5' end and degenerations at the 3' end (table 5). Specifically, degenerative oligo-dT 




I I Table 3. Primer sets used for CPEB1-4 and ~-actin in regular RT-PCR 
r. 
Gene Primer Sequence 
~-actin fwd 5' -TGAAGATCAAGATCATTGCTCC-3' 
rev 5' -TT AAAAAAACAAAGCCATGCC-3' 
CPEB1 fwd 5'-CACCTTCCGTGTTTTTGGC-3' 
rev 5'-ATCCCAGCATACACCACTCC-3' 
CPEB2 fwd 5'-CTCTCAAGGGTCGTCTGAGC-3' 
rev 5'-AATGCATAGCCTTTTGGTGG-3' 
CPEB3 fwd 5' -CATCAAGGATAAACCGGTGC-3' 
rev 5' -GAAGAATGGGGCAAACTTCC-3' 
CPEB4 fwd 5'-ATTTTTCCTTTTCCGGAACG-3' 
rev 5'-GTATCGTTCCACTCTCTCCCC-3' 
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Table 4. Primers used to identify the alternatively spliced transcripts of CPEB3 in 
regular RT-PCR 
Gene Primer name Primer sequence 
CPEB3 #1 5' -TGTCAATGTCGTTGTGTTGAAGTTGC-3' 
#3 5' -GACTCCCACACCACAAGGATACACA-3' 
#4 5' -GAAGGCGTCTTCAAAGGGAAAGAGA-3' 
#5 5' -TATGATAAGGACTGACCATGAGCCTCTG-3' 
#7 5' -AGGAGCTATGGGCGGAGACGA-3' 
#8 5' -GCTGAGTCCCCAATGCCTTAGC-3' 
#13 5' -CCCGTTTGTCAATGTCGTTGTGTT -3' 
#16 5' -AAGGATAAACCGTTGAACTGGCA-3' 
#17 5' -CATGAGCCTCTGAAAGGTAAACACT-3' 
#18 5' -AAGACCGACCTCGTCTCCGC-3' 
#19 5' -CATGAGCCTCTGAAAGGACGC-3' 
#20 5' -GAAGACCGACTGTTAAGTGCCATA-3' 
#21 5' -TTCGAGCTGTTGAACTGGCA-3' 
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Figure 17. Diagram of 3' RACE 
3' RACE (rapid amplification of cDNA ends)-PCR were used for the identification of CPE, 
PAS-containing mRNAs from the mouse retina. 
Oligo(dT) primers with anchor sequences attached to the 5' ends were used for the 
reverse transcription. The resulted cDNA pool has a ubiquitous anchor sequence at the 
3' end. 
Nested PCR were used for the amplification. For the first round, forward primers 
containing CPE consensus sequence paired with reverse primers - 3' outer primers (part 
of the anchor region) were used. For the second round, forward primers containing PAS 
consensus sequence paired with reverse primers - 3' inner primer (part of the anchor 
region) were used. For both PCR reactions, the first 3-5 rounds were carried out with 



















Table 5. Primers used for 3' RACE 
Primer 
3' RACE Adapter Primer 
3' RACE Outer Primer 




5'GCGAGCACAGAATT AAT ACGACTCACT AT AGGT12VN3' 
5'GCGAGCACAGAATT AAT ACGACT3' 
5'CGCGGATCCGAATT AAT ACGACTCACT AT AGG3' 
5'N14AAAATA3' 
5'N14TTTATT3' 
Note: The first three primers were from FirstChoice RLM-RACE kit (Ambion). It has an 
anchor at the 5' end, as well as degeneration at the 3' end. V represents any of A, C, G; 
whereas N represent any of A, C, T, and G. 
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represents any of A, T, C, or G) make the annealing specifically occur where the poly(A) 
starts, instead of randomly priming along the poly(A) tail. This primer helps to generate a 
homogeneous 3' end (with respect to the length of the poly(A) tail) for the first strand 
cDNA. M-ML V reverse transcriptase was used for reverse transcription and the 
reactons were incubated at 40°C for 1 hour. 
The cDNA was then used in two steps of nested PCR reactions: For the first PCR, 3' 
RACE outer primer and a wobbled CPE primer were used; for the second PCR, 3' RACE 
inner primer and a wobbled PAS primer were used. The 3' outer primer and the 3' inner 
primer were complementary to the outer portion and inner portion of the 3' RACE 
Adapter primer, respectively (table 5). The wobbled CPE primer and the wobbled PAS 
primer have a random 14-mers in their 5' end, followed by sequences complementary to 
CPE and PAS motifs, separately. A thermostable DNA polymerase was used for the 
nested PCR. The following settings were used for the thermocycler: 
Initial activation: 94°C,3min 
Amplification: 
3 cycles of: 94°C,30sec; 
37°C,30sec; 
72°C,30sec. 
35 cycle of: 94°C,30sec; 
60°C,30sec; 
72°C,30sec. 
Final extension: 72°C,30sec 
Because the wobbled CPE and the wobbled PAS have only 6-nucleotide match, the first 
three cycles of amplification was performed at a lower annealing temperature (3rC) to 
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ensure the sensitivity; the subsequent amplifications were performed at an annealing 
temperature of 60°C to ensure specificity. 
The PCR products were loaded to agarose gel for electrophoresis. The separated 
bands were cut out, purified, and sequenced to identify their identity. 
7. LM-PAT assay 
Several methods to determine the length of poly(A) tails of mRNA are illustrated in figure 
18. Since the amount of RNA from mouse retinas was limited, we avoided the methods 
involving Northern blots. We used the ligation-mediated polyadenylation test (LM-PAT) 
assay for our study, which is briefly described below. 
For ligation, -1119 RNA was mixed with 5'-phophor-(dT)15-mer and denatured at 65°C 
for 5 min, then transferred to 42°C without ice-quenching step. A mix of T4 ligase 
(Promega, Madison, WI) with SuperScript" buffer, dNTPs and ATPs were prewarmed at 
42°C then added to the RNA-primer mix, and incubated at 42°C for 30min. At the end of 
incubation, appropriate amount of oligo(dT)-anchor primers was added and the tube was 
transferred to 16°C for 2 hours. 
For reverse transcription, the tube was transferred to 42°C for 2min. SuperScript" 
RNase H- reverse transcriptase (Invitrogen, Carlsbad, CA) was added and incubated at 
42°C for 1 hour. Afterward, ligase and reverse transcriptase were inactivated by 
incubating at 65°C for 20min. 
PCR was performed using HotStarTaq (Qiagen, Valencia, CA). The cDNA from the 
above ligation and RT reactions, gene-specific primers, and anchor primers (table 6) 
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Figure 18. Determination of poly(A) length (Salles et al. 1999) 
a) Northern blot. The RNA molecule with longer poly(A) tail migrates at a slower 
rate. 
b) Oligo(dT)/RNase H Northern. Poly(A) tails are annealed to Oligo(dT) before 
RNase H treatment, which removes RNA:DNA hybrid - the complete poly(A). 
RNase H treated samples are compared to untreated samples in the subsequent 
Northern blot. An approximate length of poly(A) tail can be inferred with this 
method. 
c) Rapid amplification of cDNA ends-PAT (RACE-PAT): Oligo(dT) primers with 
anchors sequence attached to the 5' ends are used for reverse transcription 
reaction. A gene-specific primer and an anchor primer are used for the following 
PCR reactions. The mRNA with a longer poly(A) tail will generate a longer 
smear (a mixture of amplicon with partial or full-length poly(A) tail). 
d) Ligation mediated PAT (LM-PAT): Oligo(dT) primers and oligo(dT) primers with 
anchor sequences attached to the 5' ends are used. A ligation step is performed 
before the reverse transcription reaction to ligate these oligo(dT) together. A 
gene-specific primer and an anchor primer are used for the subsequent PCR 
reactions. The amplicons generated using this method is less heterogeneous 
compared to c). The position of the smear on the PCR gel reflect the relative 












Table 6. Primers used for PAT assay 
General primers 
anchored oligo-dT primer 
anchor-only primer 
5' phosphorylated oligo-dT 






IRBP pat fwd 
TTR pat fwd 










Note: Anchored oligo-dT primers and 5' phosphorylated oligo-dT primers were used for 
the reverse transcription step; anchor-only primers and gene-specific primers were used 
for the PCR step. 
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were assembled according to the manufacturer's instructions. PCR was run at the 
following conditions: 
Initial activation: 95°C, 15min. 
Amplification: 
35 cycles of: 94°C,30sec; 
60°C, 30sec; 
72°C,30sec; 
Final extension: 72°C, 10min. 
The PCR products were separated via agarose gel electrophoresis. The length of 
poly(A) tails was indicated by the length of the smear. 
8. Quantification of mRNA: real-time PCR 
0.2119 of total retinal RNA from each of the seven developmental ages was used for 
reverse transcription in preparation of cDNA for subsequent real-time PCR. High 
capacity cDNA archive kit (Applied Biosystems, Foster City, CA) was used for the 
reverse transcription to ensure quantitative conversion of RNA to cDNA. Components 
were assembled according to the manufacturer's protocol. The following temperature 




The resulted cDNA was diluted 1 :20 and 5ul of the dilution was used for each real-time 
PCR reaction that follows. The Gene Expression Assays - the mixture of gene-specific 
primers and gene-specific, FAM-Iabeled probes, were optimized to ensure similar 
amplification efficiencies (Applied Biosystems). 2x PCR master mix containing Taq DNA 
polymerase, dNTPs and optimized reaction buffer was used (Applied Biosystems). 188 
was used as the endogenous control. PCR reactions were performed on ABI 7300 real-
time PCR system with the following conditions: 
50°C 2min 
95°C 10min 
40 cycles of: 
94°C 15sec 
60°C 1min 
Data was analyzed using 8082.1 software (Applied Biosystems). RNA quantity for each 
sample was first normalized to the quantity of 188 in the same sample, and then 
calibrated to postnatal day 1 (P1) sample to get the relative fold change. The 
manufacturer's IDs of Gene Expression Assays for each gene are listed in table 7. The 
locations that the CPEB3 Gene Expression Assay matches on each transcript variant 
are listed in table 8. The primers-probe set generates a product spanning two adjacent 
exons which represents all known CPEB3 transcription isoforms. 
9. In situ hybridization 
121lm frozen sections were used for in situ hybridization. For each gene, sense RNA 
probe (the complementary sequence of the antisense RNA probe) was used as negative 
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Table 7. Gene Expression Assays used for real-time PCR 









Ppp2r1 a (PR 65) 










Mm00437967 _m 1 
Mm00442479_m1 
Mm00772799 _m 1 
Mm00511698_m1 
Mm00450075_m 1 
Mm00443267 _m 1 
Note: the _m in the catalog numbers indicate that the primers/probe set only amplified 
mRNA; while the _s indicates that the primer/probe set amplifies within a single 
exon, so it does not distinguish genomic DNA from mRNA. 
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Table 8. Match locations of CPEB3 Gene Expression Assay on each CPEB3 transcript 
Gene Accession Exon Boundary Assay Location Amplicon Length 
NM_198300.2 4-5 1084 79 
AK029261.1 4-5 1144 79 
AK044639.1 4-5 1264 79 
AK044639.1 4-5 1084 79 
AB093274.1 4-5 1191 79 
AK147243.1 4-5 1552 79 
AK161513.1 4-5 1238 79 





control. Primers (lOT, Coralville, IA) used in PCR amplification to generate the template 
for probes are listed in table 9. PCR products were visualized on agarose gel and the 
specific band was cut out and purified using QIAquick Gel Extraction Kit (Qiagen, 
Valencia, CA). The identity of the purified product was confirmed by sequencing 
analysis, which was later used as template for in vitro transcription to generate OIG-
labeled RNA probes (Invitrogen, Carlsbad, CA). RNA probes were denatured at 85°C 
for 5 minutes then chilled on ice. Slides were treated with 0.1 M RNase-free 
triethanolamine (TEA)-HCI pH 8.0 for 5 min, washed, and pre-hybridized at room 
temperature for an hour in hybridization buffer, which was then replaced with 
hybridization solution containing 100-200nglml of RNA probes for overnight incubation at 
65°C. On the second day, slides were washed in 0.2xSSC several times then 
transferred to buffer B1 (0.1 M Tris, 0.5M NaCI, pH7.5) for 5 minutes. Slides were then 
incubated in buffer B2 (buffer B 1 with 10% heat-inactivated sheep serum) for 1 hour at 
room temp, after which buffer B2 was replaced with buffer B2 containing anti-DIG 
antibody (1 :5000) for overnight incubation. On the third day, slides were washed, 
equilibrated in buffer B3 (0.1 M Tris, 0.1 M NaCI, 50mM MgCI2, pH9.5), and colorization 
reaction was carried out in buffer B4 (buffer B3 with 201l1/mi NBT/BCIP stock solution 
and 0.1 % tween-20). Slides were then mounted in Mowiol mounting medium for 
observation under the microscope. 
10. Isolation of proteins 
Frozen retina was homogenized using a sonicator (Biologics, Manassas, VA). 
Appropriated amount of pre-chilled CelLytic MT Lysis buffer (Sigma, St. Louis, MO) with 
1 % (v/v) protease inhibitor cocktail (Sigma) was added to the frozen tissue. Sample was 
immediately homogenized on ice at a moderated pulse and moderate power level. 
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Table 9. Primers used for in situ hybridization 
Probe Forward primer Reverse primer 
CPEB1- 5'T AGCAATGCCAAT ATCTTTCGAAGG 5'GTAAT ACGACTCACTATAGGG 
antisense 3' TGGTCTGATCCAGAGCTGAA3' 
CPEB1- sense 5'GTAAT ACGACTCACTATAGGGT AG 5'TGGTCTGATCCAGAGCTGAA3' 
CAATGCCAAT ATCTTTCGAAGG3' 
CPEB2- 5'TGAGCAGCCAGAAGAGGAAAGAGT 5'GTAAT ACGACTCACTATAGGG 
antisense T 3' TGTGTT ACT ATTGTTGTCTG3' 
CPEB2- sense 5'GTAATACGACTCACTATAGGGTGA 5' TGTGTT ACT ATTGTTGTCTG3' 
GCAGCCAGAAGAGGAAAGAGTT 3' 
CPEB3- 5' ACAGAGCCAGCTGCGCAAACCA3' 5'GTAAT ACGACTCACTAT AGGG 
antisense GAAGGTGCCTCCGAAGACCG3' 
CPEB3- sense 5'GT AAT ACGACTCACT ATAGGG 5'GAAGGTGCCTCCGAAGACCG3' 
ACAGAGCCAGCTGCGCAAACCA3' 
CPEB4- 5'GGAGGAAAGACGTGAGACATT AGG 5'GTAAT ACGACTCACTAT AGGG 
antisense T 3' TGTCAACACTGGTGATTCAA3' 
CPEB4- sense 5'GT AATACGACTCACTATAGGGGGA 5' TGTCAACACTGGTGATTCAA3' 
GGAAAGACGTGAGACATTAGGT 3' 
Note: The sequences in bold is T7 promoter. 
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Samples were then centrifuged at 4°C at 1000xg for 10 minutes to remove tissue debris. 
Supernatant were collected and transferred to new tubes. 
Protein concentration was determined using Bradford assay (Sigma, St. Louis, MO). 
Briefly, BSA standard (Sigma) of 0.125mg/ml to 2.0mg/ml was used to generate the 
standard curve. An R2 >=0.99 for the standard curve was considered acceptable. 
Several dilutions were used for unknown samples. Original concentration of the retina 
samples were calculated based on the diluted readings that fell within the range of the 
standard curve. The samples were then dispensed into aliquots and stored in -80°C. 
11. Immunofluorescence microscopy 
121lm frozen sections were used for immunohistochemistry. All steps were carried out at 
room temperature. Sections were treated with TBS with 0.05% Triton for fifteen minutes, 
and then blocked with 10% normal donkey serum in TBS for 1 hour. Sections were then 
incubated with the primary antibodies at the indicated concentrations (table 10) for 1 
hour. After several washes, fluorescence-conjugated secondary antibodies were applied 
and incubated for 1 hour. Slides were washed again and subsequently cover-slipped in 
Vectashield mounting medium (Vector Laboratories, Burlingame, CA) and observed 
under Fluoview confocal microscope (Olympus, La Jolla, CA). Negative controls with 
primary antibodies omitted were used for all experiments. Negative controls with 
primary antibodies pre-adsorbed with an immunogenic peptide or recombinant proteins 
were applied when possible. 
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Table 10. Antibodies used for immunofluorescence 
Antibodies Catalog and Company Work Concentration 
CPEB1 Custom antibody 1 :30,000 
Affinity Bioreagents 
CPEB3 Ab10883 1 :1000 
Abcam 
GAPDH Img-5019A 1:5000 
Imgenex 
HRP conjugated secondary AP187P 1 :30,000 
antibody, goat anti rabbit Millipore 
HRP conjugated secondary AP130P 1 :30,000 
antibody, goat anti mouse Millipore 
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12. Recombinant proteins 
The cDNAs of full-length CPEBs were cloned into pGEX2T vector with a glutathionine S-
transferase (GST) tag at the 5' end. The plasmid was transformed to E. coli B21 cells 
(Keyclone, Cincinnati, OH). For the expression of the proteins, B21 cells were cultured 
in Luria Broth (LB) medium at 37°C until the 0.0. 600 reached 0.4. Then isopropyl 13-0-
1-thiogalactopyranoside (IPTG) was added to the culture to a final concentration of 
0.8mM. Cells were allowed to grow for several hours. When the 0.0.600 reached 1.5-
3.0, cells were harvested and proteins extracted using B-PER bacterial protein extraction 
reagent (Pierce, Rockford, IL). Total proteins (soluble and insoluble proteins altogether) 
were loaded to polyacrylamide gel electrophoresis (PAGE) gel and stained with 
Coomassie Blue. The extra band presented in the induced samples compared to the 
non-induced was purified with the aid of immunoprecipitation. The sequence of the 
purified band was confirmed by mass spectrometry. 
CPEB proteins were predominantly expressed as insoluble forms in inclusion bodies. In 
order for the recombinant proteins to be used for antibody pre-adsorption, they must be 
solubilized. Therefore, the following treatments were performed: First, inclusion bodies 
were purified from the whole cell lysate using B-PER bacterial protein extraction reagent 
(Pierce); secondly, they were solubilized in Inclusion Body Solubilization Reagent 
(Pierce); and lastly, solubilized proteins were returned to physiological conditions via 
dialysis. A brief description of each step was as follows: 
For the purification of inclusion bodies, induced culture was collected and centrifuged at 
5000xg for 10min. Appropriate amount of Bacterial Protein Extraction Reagent (B-PER) 
with 1 :100 (v/v) proteases inhibitors (Pierce, Rockford, IL) was added to the pellet (cells). 
Cells were lysed and homogenized by pipetting and vortexing until the suspension was 
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homogeneous. The homogenate was centrifuged at 15,OOOxg for 15min at 4°C to 
separate soluble proteins and insoluble proteins. Appropriate amount of B-PER was 
added to the pellet (inclusion bodies) and resuspended. Lysozyme was added to a final 
concentration of 2001lg/ml followed by 5min incubation at room temp. 1: 1 0 diluted B-
PER was added to the tube, vortexed and centrifuged at 15,OOOxg for 15min. Pellets 
was collected, resuspended in 1: 1 0 B-PER and centrifuged. This step was repeated two 
more times. The pellet was collected for further treatment. 
For solubilization, the pellet of purified inclusion body was resuspended in appropriate 
amount of Inclusion Body Solubilization Reagent by vigorous vortex or by pipetting. The 
suspension was shaken for 30min and centrifuged at 27,OOOxg for 15min to remove cell 
debris. The suspension was the solubilized proteins from the inclusion body. Because 
the Inclusion Body Solubilization Reagent contains high amount of strong denaturant, 
proteins in this buffer have to be dialyzed before they can be used for antibody pre-
adsorption. 
Dialysis was performed at 4°C to maintain protein stability. Solubilized protein samples 
were put into Slide-A-Lyzer cassettes (Pierce) of appropriate molecular cutoff. The 
cassette with sample was put in 1 L of 6M urea and dialyzed for 6 hours. 250m I of 25mM 
Tris·HCI (pH7.5) was added to the container every 6-12 hours, until the volume reached 
3L. The dialysis solution was then replaced with 2L of 25mM Tris·HCI (pH7.5) and 
150mM NaCI, followed by another 6-hour dialysis. The sample was removed from the 
cassette and centrifuged to remove any insoluble material. The concentration of the 
supernatant (the soluble recombinant protein) was determined using Bradford Assay 







10 mg of total protein from the retina, 10l1g of CPEB3 antibody, and S0l11 SO% protein A 
plus slurry (Thermo Fisher Scientific, Rockford, IL) were used for each 
immunoprecipitation reaction. PBS buffer (NaCI 1S0mM, phosphate 10mM, pH7.4) was 
used as wash/binding buffer. The protein sample and the antibody were mixed and 
incubated on a rotator at 4·C for 3 hours. Protein A plus beads (SO% slurry) were 
washed three times in PBS and added to the antigen-antibody mixture and incubated on 
a rotator at 4·C for overnight. The complex was centrifuged at 2SOOxg for 3 minutes, 
washed three times with PBS, and reconstituted in 30-S0111 2x Lamilli sample loading 
buffer. The complex was then heated at 9S·C for S minutes, and analyzed by gel 
electrophoresis. Gel was stained with Gel Code Blue (Thermo Fisher Scientific, 
Rockford, IL) and destained with water, then cut into several portions for mass 
spectrometry. 
14. Quantification of proteins: Western blotting 
2SI1g of total protein from each sample was used for Western blots. Protein standards of 
10kO to 2SOkO (Thermo Fisher Scientific, Rockford, IL) was used as markers. 2x 
Laemmli buffer (Sigma, St. Louis, MO) was added to the samples and boiled at 9SoC for 
Smin. Samples were loaded to SOS-PAGE for gel electrophoresis. Proteins were 
transferred from the gel to O.4Sl1m polyvinylidene fluoride (PVOF) membrane using a 
Semi-dry transfer apparatus (Biorad, Hercules, CA). The blots were blocked with 10% 
milk for 1 hour, before primary antibodies were added for overnight incubation at 4°C. 
The blots were washed in TBS with 0.3% tween-20, and then incubated in secondary 
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antibody for 1 hour at room temp. The blots were washed thoroughly before enhanced 
chemiluminescence reagent (Thermo Fisher Scientific, Rockford, IL) was used to detect 
the signal. The source and dilutions of the primary and secondary antibodies used are 
listed in table 11. Recombinant proteins or immunogenic peptides were used to pre-
adsorb the antibody at a ratio of 10:1 (mass/mass) to demonstrate the specificity of the 
antibody. 
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Table 11. Antibodies used for Western blots 
Antibodies Catalog and Source Work Concentration 
CPEB1 Custom antibody 1 :400 
Affinity Bioreagents 
CPEB3 Ab10883 1:50 
Abeam 
Map1a M4278 1:200 
Sigma 
ChAT AP144-p 1 :200 
Millipore 
Alexa Fluor® 594 A21207 1:200 
donkey anti-rabbit IgG Invitrogen (H+L) 
Alexa Fluor® 488 A21202 1:200 
donkey anti-mouse IgG Invitrogen 
Alexa Fluor® 488 A11055 1 :200 




1. CPEB1 expression and regulation 
One previous study reported the presence of CPEB1 mRNA in the mouse retina using 
PCR (Liu et al. 2000). In this study we set out to confirm this initial observation. 
Additionally, we set out to demonstrate the localization of CPEB1 mRNA and protein in 
the mouse retina; the expression patterns of CPEB1 during postnatal development of the 
retina; and potential mRNA targets for CPEB1 in the retina. 
To confirm the previous finding, we first performed regular RT-PCR using a set of 
primers that were different from the prior study. We used total RNA collected from the 
retinas of adult mice. The primers we used for CPEB1 had low homology with the other 
three known CPEBs, and had no significant homology to any other gene. The amplified 
band was cut out and sequenced for validation. ~-actin primers were used as a positive 
control and a negative control; the latter had all the components except that the reverse 
transcriptase was omitted in the RT step. The result demonstrated that CPEB1 mRNA is 
expressed in retina of the adult mouse (figure 19). The absence of signal in the negative 
control indicated no contamination in any component of the RT or PCR steps, or during 
the setup of these reactions. 
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Figure 19. Presence of CPEB1 mRNA in the retina 
Total RNA from postnatal day 30 mice retina was used. Regular RT-PCR was 
conducted using CPEB 1 primers that span exons to exclude amplification of genomic 
DNA. l3-actin was used as a positive control. A reaction with only reverse transcriptase 
omitted for reverse transcription but with all the other components for RT and PCR (with 
l3-actin primers) was used as a negative control. The amplified band was sequenced for 
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1) Localization of CPEB1 mRNA 
Next, we explored the localization of CPEB1 mRNA in mouse retina with the aid of 
in situ hybridization. Antisense RNA probes were made with primers specifically 
designed for CPEB 1. The sense RNA probe from the same region was used as a 
negative control. Amplified templates of both antisense and sense probes were 
sequenced to confirm the specificity. The clean background in tissue probed with 
sense probe indicated the specificity of the anti-sense hybridization (figure 20 
upper panel). Results in tissue hybridized with antisense probe demonstrated that 
CPEB1 mRNA is predominantly localized in the inner retina, particularly in the 
RGC layer, and to some extent, the inner part of the INL (figure 20 lower panel). 
The IPL and OPL appeared to be positive for CPEB1 as well, but the synaptic 
structures of these layers could not be distinguished at this point due to the 
limitation on the resolution of in situ hybridization techniques. The localization of 
CPEB1 protein would be further explored using immunofluorescence microscopy 
(see below). 
2) Developmental regulation of CPEB1 mRNA 
The next question concerned the possible regulation of CPEB1 mRNA. To explore this 
issue mRNA levels were compared during postnatal development with the aid of real-
time PCR. Total retinal RNAs from seven developmental ages which included the eye-
opening event (approximately day 14 in mice) were used. Taking into consideration that 
physiological responses of the retina to ambient light might cause circadian regulation of 
certain genes, all the tissues were collected at the same time of the day. Both the 
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Figure 20. Localization of CPEB1 mRNA in the retina 
P60 mouse retina was used for in situ hybridization. Mouse CPEB1 primers were 
designed with low homology to the other three CPESs and to any other mouse genes. 
The primers were used to make the antisense probe of about 500bp-long whose identify 
was confirmed via sequencing. The sense probe at exactly the same location was used 
as a negative control. The results indicated that CPEB1 is highly expressed in RGC 
layer, and to a less extent, in the INL, especially inner layers of INL. CPEB1 mRNA also 
appeared to be present in the plexiform layers. Due to the limitation on the resolution of 
this method, we could not identify synaptic structures in the plexiform layer at this point. 















CPEB1 primer set and the 6-carboxyfluorescein (FAM)-Iabeled CPEB1 probes (Applied 
biosystems) were gene-specific which ensured stringent specificity. 
Our data demonstrated an up-regulation in the level of CPEB1 mRNA throughout the 
period of postnatal development into adulthood (figure 21). A significant increase 
(p<0.05) of 2.5 fold was observed in P12 compared to P1. No significant changes were 
found between P12 and p16. Whereas the older animals, P30 and P60, demonstrated 
another significant increase compared to P14 and P16, respectively. The overall 
increase in the level of CPEB1 transcripts was about 6 fold in adult animals (P60) 
compared to newborns (P1). The data appeared to be consistent with the notion that 
some aspect of development regulates CPEB1 transcription. The data are less clear as 
to whether eye opening makes any significant impact on the course of this 
developmental regulation. 
3) Localization of CPEB1 protein in the retina 
To confirm and extend the observations from the in situ hybridization data, fluorescence 
immunocytochemistry was performed with an antibody to CPEB-1 on fixed tissue 
sections of the retina. The results of these studies indicated that CPEB1-protein is 
clearly located in the neuronal processes that make up the inner plexiform layer. At 
least two laminar structures are distinguishable in the INL (figure 22, 23). Cell bodies in 
the RGC layer are immunopositive for CPEB1 and some cell bodies in the INL are 
immunopositive for CPEB1. 
To identify the cell phenotypes expressing CPEB1, we used double labeling, combining 















Figure 21. Developmental pattern of CPEB1 mRNA 
Total RNA from the retinas of postnatal day1, 7, 12, 14, 16, 30, and 60 which were 
collected at the same time of the day was used for real-time PCR assays. The 
combination of gene-specific primers and FAM-Iabeled gene-specific probes ensured 
high specificity. 18S was used as an endogenous control. The relative fold changes 
were acquired by calibrating all the older ages to age P1. Each age had 6-10 animals. 
The Anova procedure, Tukey's Studentized Range (HSD) was used for statistics. Error 
bars indicated standard deviation (SO). Significant changes were found between each 
two bracketed ages (p<0.05). The results demonstrated an overall up-regulation of 
CPEB1 transcripts during postnatal development. A significant increase (2.5 fold) was 
found in P12 compared to P1. P12-16 showed no significant changes. The level of 
CPEB1 mRNA continued to increase significantly from P16 until the adulthood (P60). 
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Figure 22. Localization of CPEB1 protein - with MAP1 a 
P16 retina was used for the immunohistochemistry. CPEB1 was expressed in some 
cells in the retinal ganglion cell (RGC) layer. The double labeling of CPEB1 and MAP1a 
demonstrated that some CPEB1 positive cells were MAP1a positive (arrows); while 
other CPEB1 positive cells in RGC layer were MAP1a negative (arrowheads). This 
indicated that some, but not all, CPEB1 positive cells in the RGC layer were ganglion 
cells. The MAP1 a labeling in outer plexiform layer (OPL) was non-specific since it also 
appeared in no primary negative controls. CPEB1 was also highly expressed in the 
inner plexiform layer (IPL), with some laminar pattern. A few cells in the inner nuclear 




Figure 23. Localization of CPEB1 - with ChAT 
P16 mouse retina was used for immunohistochemistry. CPEB1 was expressed in some 
cells in the retinal ganglion cell (RGC) layer. The double labeling of CPEB1 and ChAT 
demonstrated that some CPEB1 positive cells were ChAT positive (arrows); while other 
CPEB1 positive cells in RGC layer were ChAT negative (arrowheads). This indicated 
, that some, but not all, CPEB1 positive cells in the RGC layer were displaced amacrine 
cells. CPEB1 was also highly expressed in the inner retina, with some laminar pattern. 
The two distinguishable laminae ( small open arrows) appeared not to be co-localized 
with ChAT, suggesting that they were not cholinergic synapses. The close juxtaposition 
of these two laminae with ChAT positive laminae raised the possibility that they may be 
localized in sublamina a and sublamina b respectively. A few cells in the inner nuclear 
layer were CPEB1 positive, some being ChAT positive (big open arrows), and others 
ChAT negative (big open arrowheads). This suggested some of the CPEB1 positive 
cells in the INL were cholinergic amacrine cell, the others were not. The scale bar 




and Matus 1988), or a cholinergic amacrine cell marker choline acetyl transferase (ChAT) 
(Kang et al. 2004; Eckenstein and Thoenen 1982; Voigt 1986; Zhang et al. 2005). Our 
data demonstrated that the CPEB1 positive cells in RGC layer can be MAP1a positive 
(figure 22), or ChAT positive (figure 23). This suggested that some CPEB1 positive cells 
in the RGC layer are retinal ganglion neurons, and some are displaced amacrine cells. 
Some, but not all CPEB1 positive cells in the inner layers of INL are ChAT positive, 
indicating that some of those cells are cholinergic amacrine cells. The CPEB1+/ChAT-
cells in the INL could be other types of amacrine cells, or bipolar cells. To determine all 
phenotypes of cells expressing CPEBs would require an extensive study of double and 
triple antibody labeling with antibodies to known cell markers which is beyond the scope 
of this dissertation. 
CPEB1 immunolabeled tissue sections showed distinguishable patterns during 
development. Throughout all developmental ages examined, CPEB1 was highly 
expressed in the IPL. The labeling of CPEB1 was across the IPL, but some 
distinguishable laminar structures were labeled at a higher level. These laminar . 
structures did not appear to co-localize with ChAT labeling (figure 23). This suggested 
that these synaptic layers are not cholinergic. However, these CPEB1 positive laminae 
are within close proximity to the ChAT positive laminae. A dark "furrow" lay between two 
laminar structures in the CPEB1 staining. 
4) Developmental regulation of CPEB1 proteins in the retina 
To expand our observation of the developing pattern of CPEB1 mRNA, we looked at the 
levels of CPEB1 proteins during development with the aid of Western blots. To validate 
the specificity of the antibody, the immunogen, a peptide used to generate the antibody 
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was used in pre-adsorption experiments as the negative control (figure 24b). The results 
from Western blots (figure 24a) indicated that qualitatively the level of CPEB1 protein 
was up-regulated in the retina during the postnatal development, which is consistent with 
our observation on the developmental pattern of CPEB1 mRNA (figure 21). 
5) Identification of CPE-containing mRNAs in mouse database using a bioinformatics 
program 
Two consensus sequences for CPEs in mRNAs that contain such regulatory sequences 
have been published. These include: UUUUUAU and UUUUAAU (Fox et al. 1989; 
Simon et al. 1992). However, very few gene-transcripts are known targets of CPEB1 in 
the central nervous system. To identify potential mRNA targets of CPEB1 using the 
current knowledge of CPE sequences, two approaches were used to explore this 
relatively new area. The approaches adopted included the use of a home-grown 
bioinformatics program, and the use of a specialized 3' RACE RT-PCR. 
The bioinformatics program was designed with the help and collaboration of Dr. Eric 
Rouchka in the Department of Computer Engineering and Computer Sciences and 
named "CPE Detector". This program searched the 3' UTR databases UTRdb 
(www.ba.itb.cnr.itlUTRI) for the presence of the CPE consensus motif, the PAS 
consensus motif, the relative location of the two (CPE may partially overlap with PAS, 
but is always upstream of PAS), and the length of the gap between the two. Genes with 
the required characteristics were retrieved and classified into different categories based 
on the length of the gap (table 12). Several redundant or non-redundant databases 
ranging from fungus to human were used. From the non-redundant mouse 3'UTR 
database, we identified a total of 1449 genes that have at least one CPE upstream of the 
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Figure 24. Developmental pattern of CPEB1 protein 
a) Total retinal proteins of P1-P60 mice were used for western blots. Qualitatively 
the level of CPEB1 protein in the retina was up-regulated during postnatal 
development. This is consistent with real time PCR data. 
b) To ensure the specificity of the antibody, synthetic immunogenic peptide was 
used to pre-absorb the antibody before applying the antibody to the blot. Pre-
adsorption diminished the band which suggested that the detected band was 
specific for CPEB1. 
112 
Figure 24 




PAS. Among them 185 genes have a gap of 10-50bp, 190 have a gap of 51-1 OObp; 127 
have a gap of 10 1-150bp; 103 have a gap of 151-200bp. About 1100 genes have a gap 
longer than 201 bp. 
With the aid of the mouse UTR database (www.ba.itb.cnr.itlUTR/). we further screened 
for genes with two or more CPE motifs upstream of the PAS. After refinement of this 
program, 1045 genes with two CPE motifs and one poly(A) site in their 3' UTRs were 
identified; only 36 with a spacer of less than 250bp (table 13). Some of the genes 
thought to be likely candidates were subjected to polyadenylation tests (PAT) (table 14). 
6) 3' RACE-PCR to identify CPE containing mRNAs specifically from mouse retina 
To identify the potential retinal mRNAs with CPE and PAS in their sequences, a 
specialized 3' RACE RT-PCR method was developed. Total mouse retinal RNAs were 
used in two rounds of nested 3' RACE PCA. The first round amplified specifically CPE-
containing mRNAs; while the second round amplified, in the population derived from the 
first round of PCR, specifically PAS-containing mRNAs. A highly repeatable pattern was 
acquired with this method (figure 25). Each distinguishable band was cut out, purified, 
and sequenced. The identities of these sequences were determined by comparing their 
sequences to the nucleotide database using Blastn 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). 
One of the possible limitations of this method was that it did not distinguish CPE/PAS 
within the 3' UTR from CPE/PAS within the other regions of the gene. After sequencing, 
only one gene from these bands, transthyretin (TTR), truly had a CPE/PAS in its 3' UTA. 
TTR encodes for a transport protein for retinol. Its mRNA has been localized in the 





Table 12. CPE-containing mRNAs identified using "CPE Detector" program 
Number of genes identified from the databases using "CPE Detector" (developed in collaboration with Dr. Eric Rouchka). Redundant 
(R) or non redundant (NR) 3' UTR databases for different organisms were used. Candidate genes extracted were categorized 
according to the length of the gap between CPE and PAS. The results derived from mouse and rodent databases were highlighted. 
# of Nucleotides between patterns 
Num.3' 
UTRs UNFILTERED 1 Oto50 51to100 101to150 151to200 201to300 301to400 401to500 501+ 
FUNGAL NR 3122 54 18 19 12 7 6 2 0 3 
FUNGAL R 673 15 5 5 2 3 1 1 0 1 
HUMAN NR 35701 3335 432 406 332 353 572 490 426 1842 
HUMAN R 31156 1913 317 239 191 209 316 271 202 827 
INVERTEBRATES NR 23849 1178 251 248 187 169 214 165 126 318 
INVERTEBRATES R 5735 224 60 52 28 38 28 10 22 47 
MAMMALS NR 7789 262 39 35 27 20 36 41 26 112 
MAMMALS R 2359 42 13 3 6 8 3 12 3 17 





MOUSE NR 18342 1449 185 190 127 103 168 178 152 761 
MOUSE R 13784 517 107 71 59 36 59 50 62 198 
~~ 
-
-- - - - - - - -
PATENT NR 559 31 7 5 3 1 7 9 2 13 
PATENT R 257 9 1 2 0 0 1 2 0 4 
Plant NR 39483 395 132 118 83 33 22 16 4 10 
Plant R 19107 66 32 13 9 3 3 0 1 1 
- ~ -----. - .. 
-
. -
-- - -RODENTS NR 7408 305 40 38 39 20 49 45 42 105 








Viruses NR 5667 117 3 23 29 17 17 12 9 80 
Viruses R 17086 172 0 16 8 2 13 2 10 142 
Vertebrate NR 1721 254 268 260 195 343 250 224 625 
Vertebrate R 178 19 36 25 19 38 34 17 42 
12034 1920 1793 1438 1238 1900 1597 1335 5166 
Table 13. List of mouse genes with two or more CPEs upstream of PAS (within 250 bp distance) in the 3' UTR 











r BC024126 Dimethylglycine dehydrogenase precursor Q) 
BC026127 Csnk1 e (Casein kinase 1) Nerve ganglia; prosencephalon; skin yes 
BC027797 Sp3 (Trans-acting transcription factor 3) Mesencephalon; vascular tissue; lymph node Yes 
BC029814 Fos (FBJ osteosarcoma oncogene) Bone marrow; bone; liver yes 
BC030726 Casc4 (cancer susceptibility candidate 4) Nerve ganglia; prosencephalon; cerebellum yes 
BC031438 Extl2 (Exotoses (multiple)-like 2) Basal ganglia; nerve ganglia; skin yes 
BC037478 Extl2 (Exotoses (multiple)-Iike 2) Basal ganglia; nerve ganglia; skin yes 
BC040201 Zfp715 (Zinc finger protein 715) Endocrine gland; lymph node; whole brain yes 
BC048845 Inhbb (Inhibin beta-B) Female genital; mammary gland; lung Yes,·not top3 
BC050916 Crsp3 (cofactor required for Sp1 transcriptional Blood; whole brain; ear yes 
activation, subunit 3 
C054845 Gent2 (Glucosaminyr(n-acetyl) transferase 2) GalfllladCter; vascular; extraembryonic tissue Yes (not top 3) 
BC057182 Brd1 (Bromodomain containing 1) Bone; whole brain; eye Yes 
BC057543 Lefl (Lymphoid enhancer binding factor 1) Thymus; skin; spleen small 
. -~ BC060175 
BC062954 Ehd2 (EH-domain containing 2) Lymph node; vascular tissue; thymus; cerebellum Yes 
BC064446 Casc4 (cancer susceptibility candidate 4) Nerve ganglia; prosencephalon; cerebellum Yes 
X69620 Inhbb (Inhibin beta-B) Female genital; mammary gland; lung Yes (not top 3) 
M60803 NA NA NA 
KOOO2O Ifnb1 (Interferon beta 1, fibroblast) NA NA 
..... 
..... 
-...J AK129312 Crsp3 (Cofactor required for Sp1 transcriptional Blood; whole brain ; ear yes 
activation, subunit 3) 
AY435148 Gent2 (Glucosaminyl (N-acetyl) transferase 2) Gall bladder; vascular; extraembryonic tissue Yes (not top 3) 
AY435149 Gent2 (Glucosaminyl (N-acetyl) transferase 2) Gall bladder; vascular; extraembryonic tissue Yes (not top 3) 
AY435150 Gent2 (Glucosaminyl (N-acetyl) transferase 2) Gall bladder; vascular; extraembryonic tissue Yes (Rot top 3) 
BCOO5508 Crsp3 (cofactor required for SP1 transcriptional Blood; whole brain; ear yes 
activation, subunit 3 
BC018497 Arl-6 (ADP-ribosylatlon factor-like 6) Embryonic tissue; eye; limb yes 
BC040386 Zfp715 (zinc finger protein 715) Endocrine gland; lymph node; whole brain yes 
BC057313 Zfp715 (zinc finger protein 715) Endocrine gland; lymph node; whole brain yes 
M31131 Cdh2 (cadherin 2) Eye; whole brain; heart yes 
Table 14. Sequences and locations of CPE, PAS, and linker of eight CPE-containing mRNAs 
Gene Accession 1st CPE 1st CPE Hex Hex Linker Seq Linker 
name # seguence location Seguence Location size 
Actin-beta NM_007393 T6GT4G T4G 1362- TTTAAA 1397- CGCTTTTGACTCAGGA 16 
13:nt 1802 
T4GT15G2T4 1488- TTTAAA 1690- AGTCATTCCAAGTATCCATGAAATAAGTGG 154 




T ACTGCAAAAA TTTT 
T5-A2-T 1"722- - AA,TAAA--f862- TTCTGAATGGCCCAGGTCTGAGGCCTCCC faa 




-" ACTGACTTGAG ex> BDNF NM_007540 T4AT 1502- TATAAA 1518- GAACTGCATG 9 
1507 1523 
T6.A T7 AT5 3029- AAAAAG 3070- GAGACATTTTGGGAAAAGGAAA(AAA) 22/25 




T6AT 4028- AGTAAA 4058- AGTGATTCCCATTGAAACTGTA 22 
4035 4063 
CaMKlla NM_177407 T6A2T 4669- AATAAA 4780- CTGTGGCTGTGAACTTGAATGACCACTGCT 102 
4677 4785 CAAACTTTCTGCTACTGGGGGGGTGGGGG 
AGGGGAGAAGAGATGTCTGGTTTATTCTTG 
GCGTTTTCAGTGG 
T6GT3GT3G 4879- AATAAA 4929- CAAATCTCCCCTGTTGCAA 19 
T3GT5GT3G 4909 4934 
T~ '2~el;?t 
MAPK1 NM 011949 T4GT4CT2G2 2763- AATAAA 2871- GACATCAATGGAAAATGGGTTCTATAAAGA 78 
T5 A T6 A T4 2793 2876 CTGCCTGCTAGTATGAACAGCAATGCAATG 
CACTTGTAACTC 
ATGGA 
Ppp2r1a NM_016891 T6 G T gtgt 2180- GTGTCAATTGTGCCA 52 
2187 
T5AT4AT2 2203- AATAAA 2239- CCTTTCCCTACTGTACACGGAGA 24 
2215 2244 
Ppp2r2b NM_028392 seven nt off 
compare to 
NM 027531. 
NM_027531 tgtg T4G T3 1818- CTAG-GTGTCTCrCTCrC-GATAAAATGAGATTG- 63 
1825 TCTGTAGTATTTAAGGAGAAAAAGAGATAA 
~~ 
T10 A2 T 1888- AATAAA 1945- TAAGCATTCCATTTGTTTGAAAAAAATCAAC 45 
1900 1950 AACAAAAAAAAAA 
RBP·3 NM_015745 T6A3 4842- AATAAA 4920- GGAGGACCATGCACCTGTATTGTCTAGCCT 70 
4850 4925 TGACATCTGGAAAGGCTAAGCTGTTGCTGC 
...... TCAGGGCCT ...... 
<0 Ttr NM_013697 T3 C T6 A T3 623-636 TTTAAA 674-679 CCTCATTTTTCTCCCCTGCTCCTAAAACCC 38 
AAAATTT 
T9AT 1006- AATAAA 1033- AACCTTTAGTGACTA f5 
1017 1038 
Figure 25. RACE for identification of target mRNAs of CPEB1 
Total P60 mouse retinal RNA was used for 3' RACE. An illustration of the 3' RACE 
method is shown in figure 16. The used of wobbled CPE primers and wobbled PAS 
primers in the nested 3'RACE reactions generated multiple bands. Each band was cut 









been found in RPE, the optic nerve fiber layer, as well as retinal ganglion cells of the 
retina (Dwork et al. 1990). This gene, together with several of the genes identified using 
the bioinformatic program, were used in polyadenylation assays (see below). Another 
limitation on this method was that because of the competition for the same set of primers, 
additional genes that have 3' UTR/PAS in their 3' UTRs may not be amplified to 
sufficient amount for them to be identified from the gel or in our sequence data. 
7) Polyadenylation of eight CPE-containing mRNAs in developing retina 
The following eight genes, based on their known possession of CPE/PAS motifs in their 
3' UTRs and the known or suspected presence in the retina, were selected for the PAT 
assay: CaMKlla, BDNF, l3-actin, MAPK, protein phosphatase regulatory domain 1 a 
(Ppp2r1 a), protein phosphatase regulatory domain 2b (Ppp2r2b), interstitial retinol 
binding protein (IRBP), and TTR. The number of copies and the sequences of CPE and 
PAS motifs, as well as the sequence and length of gaps between the two in these eight 
genes was confirmed (table 14). 
The experimental paradigm chosen as a putative trigger for polyadenylation was 
development. Total retinal RNA samples from mice of different ages were used for the 
LM-PAT method. The length of the poly(A) tails were visualized on agarose gel (figure 
26). The assays were repeated multiple times with consistent results indicating that 
MAPK1, Ppp2r1A, Ppp2r2B, IRBP and BDNF mRNAs acquired elongated poly(A) tails 
from P1 to P7. Ttr and BNDF had elongated poly(A) tails from P7 to P12. No profound 
changes in the length of the poly(A) tails were found for these genes in older animals 
(figure 26). The PAT which measures mRNA elongation provides supporting evidence 
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Figure 26. LM-PAT assays of potential CPEB1 targets 
Total RNA from seven ages of P1 to P60 retinas were used. An illustration of the LM-
PAT method is illustrated in figure 17. Eight genes: j3-actin, BDNF, CaMKlla, MAPK, 
Ppp2r1 a (protein phosphatase 2 regulatory subunit A), Ppp2r2b (protein phosphatase 2 
regulatory subunit B), IRBP (interstitial retinol binding protein), and TTR (transthyretin) 
were selected based on the 3' RACE results and the bioinformatics program "CPE 
Detector". GAPDH, which does not have any CPE sequence in its 3' UTR, was used as 
a control. The results demonstrated that from P1 to P7, six out of eight candidate genes 
(except j3-actin and ITR) acquired prolonged poly(A) tail. From P7 to P12, TTR gained 
prolonged poly(A) tail. 
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Figure 26 
j3-actin BDNF IRBP 
CaMKllo GAPDH TTR 
MAPK Ppp2r1a 
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that some aspect of development, especially between P1 and P7 triggers the 
translational control apparatus. 
In summary, our study confirmed the presence of CPEB1 in the mouse retina. The level 
of CPEB1, both mRNA and protein, were up-regulated throughout development. 
Potential mRNA targets of CPEB1 were identified both computationally and 
experimentally. Several genes from the candidate pool acquired elongated poly(A) tails 
during postnatal development. 
2. CPEB3 expression, regulation and isoform analysis 
Having demonstrated the expression patterns of the well established CPEB1 in the 
mouse retina, we were particularly interested to see if CPEB3 is present in the retina. 
One of the recently established target mRNAs for CPEB3, GluR2, has been shown to be 
a key player in synaptic plasticity. Although much less is known about the mechanism 
and the expression pattern of CPEB3 compared to CPEB1, it is postulated that CPEB3 
functions through a mechanism that is distinct from that of CPEB1. It may also be rather 
different from CPEB1 with regard to its tissue distribution and its mRNA substrate 
specificity. The existing state of our knowledge concerning the isoform composition of 
CPEB3 is summarized in a 2003 publication (Theis et al. 2003). Our goal in this section 
was to first expand and update this knowledge of CPEB3 isoforms and their relative 
tissue distribution, and then to establish the expression pattern of CPEB3 in the mouse 
retina. 
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1) CPEB3 has multiple unique motifs compared to CPEB1, 2 and 4. 
Four CPEB paralogs (CPEB1-4) derived from four different chromosomes have been 
identified in mouse. The N termini of CPEBs are profoundly variable, while the C termini 
are highly conserved (Theis et al. 2003). Sequence comparison demonstrates that 
CPEB3 shares higher homology with CPEB2 and CPEB4, but is distal to CPEB1 in the 
family tree. RNA recognition motifs (RRM) of CPEB3 share 97-99% identity with CPEB2 
and CPEB4, but only 45% with CPEB1 (Theis et al. 2003). Searching the complete 
sequences of CPEB2, 3 and 4 proteins, we identified multiple sequences that are unique 
to CPEB3, including a poly-glutamine (poly-Q) track, a serine-alanine (SA) track, a 23 
amino-acid motif and an 8 amino-acid motif (figure 27). They are also absent from 
CPEB1. These motifs may have functional significance with respect to the uniqueness to 
CPEB3. 
2) Multiple isoforms of CPEB3 were identified in the database using bioinformatics 
analysis 
A previous study characterized four different alternative splicing isoforms of CPEB3 
transcripts (Theis et al. 2003), in which two short motifs of 69nt and 24nt (coding for 23 
amino acids and 8 amino acids, respectively) are removed individually, or concurrently. 
However, the structure of CPEB3 seems to be more variable than previously reported. 
When investigating the nucleotide databases for CPEB3 isoforms, we were able to 
identify eight transcript variants (figure 28, isoform 1 a-1 d, 3-6). When a similar search 
was performed for the protein databases, we were able to identify seven distinct CPEB3 
protein isoforms (figure 29). With the aid of sequence alignment tools, we mapped the 
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Figure 27. Multiple unique motifs of CPEB3 protein 
Multiple unique motifs are present in CPEB3 protein, as demonstrated by sequence 
alignment of CPEB2, CPEB3, and CPEB4 proteins. A glutamine rich motif (poly-Q track), 
a 23-amino-acid fragment, and an 8-amino-acid fragment (highlighted in blue) are only 
present in CPEB3. Sequences highlighted in yellow are two RNA recognition motifs that 
are highly conserved among CPEB2-4. The phosphorylation site of CPEB3 is also 
indicated in yellow, which seems to be homologous in CPEB4. For simplicity, only 
Ref Seq sequences are used for the alignment. Accession numbers are as following: 
NP _787951.1 for CPEB2, NP _938042.2 for CPEB3, and NP _080528.2 for CPEB4. 
Asterisk indicates 100% conservation; colon indicates substitution with a similar amino 
acid; period indicates substitution with a distinct amino acid. 
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Figure 27 
CPEB3 --------------------------------------------MQDDLL 6 
CPEB2 --------------------- -----------------------------





















NNGALLFQNFPHHVSPGFGGSFSPQIGPLS- -- -----QHHPHHPH-FQH 241 
Poly Q - track 
CPEB3 PQAQPSQQRRSPAS PSQAPYAQRSAAAYGHQPIMT--SK I, 231 Phosphorylation site/AS track 
CPEB2 PVSPQLQQQHQAAA---AAFLQQRNSYNHHQPLLK--QSP---------- 56 
CPEB4 HHSQHQQQRRSPASPHPPPFTHRSAAFNQLPHLANNLNKPPSP------- 284 
CPEB3 SAS SWNTHQSV----NAAWSAPSNPWG--GLQAGRDPRRAVGV 275 
CPEB2 -----------WSNHQ------NSGWGTASMSWG--AMHG-RDHRRSG-- 84 
CPEB4 -----------WSSYQSPSPTPSSSWSPGGGGYGGWGASQGRDHRRGLN- 322 
CPEB3 GVGVGVGVPSPLNPISPLKKPFSSNVIAPPKFPRAAP-LTSKSWMEDNAF 324 
CPEB2 ----NMGIPGTMNQISPLKKPFSGNVIAPPKFTRSTPSLTPKSWIEDNVF 130 
CPEB4 ------GGITPLNSISPLKKNFASNHIQLQKYARPSSAFAPKSWMEDSLN 366 
*****'" *.., * * * • . *. .. .. . ...... . 
CPEB3 RTDN-GNNLLPFQDRS-RPYDTFNLHSLENSLMDMIRTD-HEPL ;<HY 371 23 a . a. 
CPEB2 RTDNNSNTLLPLQVRSSLQLPAWGSDSLQDSWCTAAGTSRIDQDRSRMYD 180 




iF GRMGINFHH PGTDNIMAL 0'- ~!'.P GR 418 8 a . a . (phosphosite-for CaMKIIa/Sp6) 
CPEB2 SLNMHSLENSLIDIMRAEHDPLKGRLSYPHPGTDNLLMLN-- ------GR 222 
CPEB4 ---------SLIDIMRAENDSIKGRLNYSYPGSDSSLLINARTYGRRRGQ 429 
. . . ,.. '" . '" . . 
.... . ...
CPEB3 SSLFPFEDAFLDDSHGDQA-LSSGLSSPT--RCQNGERVERYS~VFVGG 465 
CPEB2 SSLFPIDDSLLDDGHSDQVGVLNSPTCYS--AHQNGERIERFSRKVFVGG 270 




****"' .. * . k •• • •• 
... . .. 
LPPDI DEDEITASFRRFI;! .. V'''DWPHKAESKS' f"PI- ,'''; ,AF;"Lc'QE,;SSV 
LPPDIDEDEITASFRRFGPLVVDWPHKAESKSYFPPKGYAFLLFQEESSV 
LPPDIDEDEITASFRRFGPLIVDWPHKAESKSYFPPKGYAFLLFQDESSV 
***+**************** .••• ******************+++ . **** 
. . 
CPEB3 QA' f DAC: ';IJ(V. r~v', '; c·· 'DKPV\.· PPWNLSDSDFVMDGSQPLDP 
CPEB2 QALIDACIEEDGKLYLCVSSPTIKDKPVQIRPWNLSDSDFVMDGSQPLDP 
CPEB4 QALIDACIEEDGKLYLCVSSPTIKDKPVQIRPWNLSDSDFVMDGSQPLDP 






,SNQQSY IAA r SAR:"VQ;,QHND: DKR,·f. 'l'.PY\lLDDQM' 'DECQGTRCGGK 
FSNQQSYIAAISARFVQLQHGDIDKRVEVKPYVLDDQMCDECQGARCGGK 
FSNQQSYIAAISARFVQLQHGEIDKRVEVKPYVLDDQLCDECQGARCGGK 
************* ••• **** . **********'"'*.** . ****** . ***** .. . 
CPEB3 FAPFFCANVTC :,QYYCEYCWAS : HS?AC :'SFHKP iNKEGGDRi' .': HVPFRW 
CPEB2 FAPFFCANVTCLQYYCEFCWANIHSRAGREFHKPLVKEGADRPRQIHFRW 
CPEB4 FAPFFCANVTCLQYYCEYCWAAIHSRAGREFHKPLVKEGGDRPRHISFRW 
CPEB3 S 716 
CPEB2 N 521 

















The firs t RRF 
The second RRF 
cDNAs to genomic DNA and identified multiple alternatively spliced regions. We also 
inferred the matches of cDNAs variants to protein isoforms (figure 28, 29). 
Besides the two previously reported sequences whose deletion results in isoforms 2, 3, 
and 4, several other alternative splicing regions were found to be present. One location 
was near exon 11. The prototypical isoforms have exon 12 immediately following exon 
11 (figure 28, isoform 1 a-1 d, 2, 3, 4, and 6). However, the isoform 5 has an extended 
exon 11 (by "bleeding into intron 11"), which causes a completely different 3' UTR and 
the omission of exon 12 (figure 28). Consequentially, the derivative protein terminates 
with four unique amino acids (VELA) and is deprived of the second RNA binding motif 
and the zinc finger domain (figure 29, isoform 5). 
Another variable region is within exon 4. Two deletion variants can occur within this 
exon. One deletion leads to the use of an alternative starting codon, resulting in the 
removal of the first 216 amino acids in the derived protein (figure 28 and 9, isoform 6). 
The other deletion variant, for which the cDNA could not be identified in the UniGene 
nucleotide database, has a derived protein with a deletion of 83 amino acids, ending with 
the 197th serine (figure 29, isoform 7). The 197th serine can be essential for the function 
of CPEB3, since it has been recently shown to be the phosphorylation site of CPEB3 
when synaptosomes were stimulated with KCI (Munton et al. 2007). 
In addition to these splices which lead to altered protein sequences, there are other 
splices in the cDNAs which do not demonstrate differences in protein sequence, but 
rather show variance in their UTR regulatory regions. For example, alternative usage of 
exon1, 2, and 3 results in different 5' UTRs (figure 28, isoform 1 a, 1 b, 1 c); alternative 
usage of poly(A) Signals in exon 13 leads to different 3' UTRs (figure 28, isoform 1 d). 
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Figure 28. Analysis of CPEB3 transcript variants in the database 
Nine different transcripts of CPEB3 have been reported to the UniGene database or in 
research paper. 
Upper Panel: Representation of genomic sequence with boxes representing exons and 
lines representing introns. Lower Panel: The cDNAs derived from alternative splicing. 
Nine cDNAs were shown here, with their accession numbers and types of tissue (when 
available) given to the right. Partial sequence of isoform 2 (exon 5-7) was confirmed 
with PCR in a previous study (Theis et al. 2003), but we were unable to identify the 
accession number in the database, thus its complete sequence shown here was 
uncertain. The first four isoforms are named as 1 a-1 d in our study because they code 
for the same protein. The difference between these four sequences solely reside in 
untranslated regions. The translational start codons and stop codons were annotated on 
top of the genomic DNA. The alternative splices of coding exons 4, 5, 7 and 11 generate 
different proteins presented in figure 29. Alternative splices upstream of the translational 
start locations (exon 1-3) or downstream of the stop locations (exon 13) give rise to 
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Figure 29. Analysis of CPEB3 protein isoforms in the database 
Seven isoforms of CPEB3 proteins have been documented in the database. 
Isoforms 1-6 corresponded to the same numbered cDNA transcripts in figure 28. Protein 
isoform 1 was derived from the cDNA variants 1 a-1 d. The cDNA sequence for protein 
isoform 7 could not be identified in the database. For simplicity, Poly-Q (poly-glutamine), 
SA (Ser-Ala track), 23 a.a. and 8 a.a. motifs are only labeled in isoform 1. Colored 
boxes represent possible functional motifs. Boxes in dash-lines represent deletions. 
197P represents the 19ih serine phosphorylation site for CPEB3. RRM represents RNA-
recognition motif. The position of the colored-box motifs and dash-line-box motifs are 
indicated at the top and the bottom. The length, the molecular weight and the accession 
number of each isoform are indicated to the right (Swiss-ProtlTrEMBL number is un-
bracketed, NCBI number bracketed). 
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Figure 29 
11331 197 228238 459 550567 649 716 
II I I I I I I I I I 
jilP RRM1 RRM2 716aal Q7TN99-1 
Isoform1 II I I I I I I I I !.£I A 78kD (NP _938042) poly-Q SA 23a.a. Ba.a. 
jilP RRM1 RRM2 708aal II Ci I I I Isoform2 YfI& 77kD Q7TN99-2 
jilP RRM1 RRM2 693aal Q7TN99-3 II : ::: ; I I I Isoform3 \lElA 75.5kD 
jilP RRM1 RRM2 685aal QrTN99-4 
Isoform4 U : ::: ; C: I I ) \Elf 74.5kD 
197P RRM1 561aal Q7TN99-5 
Isoform5 II J: : ::: ; I I IGEWK 62kD (BAE36436) 
197P RRM1 RRM2 477aal A1A562 
Isoform6 ( ~ : : ::: ; I I I 'Fl. 53kD 
197P RRM1 RRM2 598aal (EDL41778) 
Isoform7 : ..... ~ : ......... _ .... I I I }lEI' 67kD 
I I I I I I 
105 197217 367 389 409 416 561 564 
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3) Multiple isoforms of CPEB3, including a novel isoform, were experimentally 
identified in the mouse retina. These isoforms have a wide tissue distribution; 
and only the (+69+24) variant is selectively expressed among different tissues. 
Apart from the presence of CPEB1 in the retina, we investigated whether CPEB3 mRNA 
is present within the mouse retina. The CPEB3 primer set was designed to flank multiple 
exons to exclude the genomic DNA, with no significant homology to any other genes. 
RT-PCR results demonstrated that CPEB3 is expressed in the retina (figure 30a). [3-
actin primers were used in both positive and negative controls. The negative control 
contained all necessary components except that reverse transcriptase was omitted for 
the RT step. Should there be any contamination from the reverse transcription 
components, the PCR components, or during the setup of either experiment, it would be 
amplified in the negative lane. The lack of bands in this lane confirmed that the signals 
in the other lanes are specific. 
Next, we investigated whether CPEB3 transcript variants identified through the 
bioinformatics analyses were present in the mouse retina. Total RNA isolated from P60 
mice retinas and primer sets designed spanning exon 5-7 or exon 11 (figure 30d) were 
used for RT-PCR. Amplicons of the PCR reactions were separated on agarose gel, and 
individual bands were extracted and sequenced to confirm their identity. Since partial 
sequences instead of complete sequences were amplified here, one amplicon may 
correspond to more than one of the transcripts (figure 28). Therefore, in this section, we 
used descriptional names instead of numerical isoform names for each amplicon. 
"+69+24" (corresponding to figure 28, isoform 1 a-1 d), "-69+24" (figure 28, isoform 3, 5, 
and 6), "+69-24" (figure 28, isoform 2), and "-69-24" (figure 28, isoform 4) were used to 
designate each variant in the exon 5-7 region; and "extended exon 11" (figure 28, 
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Figure 30. Tissue distribution of CPEB3 transcript variants 
a) CPEB3 is present in the P60 retina. Both the primers in CPEB3 and ~-actin span 
multiple exons to discriminate genomic DNA. 
b) RNA from adult retina was reverse transcribed and different primer sets for 
various CPEB3 isoforms (sequences listed in table1) were used for PCR. Each 
visible band was purified and sequenced to confirm its identity. This data 
demonstrated the presence of five variants: "+69nt+24nt" (lane2, upper band), "-
69nt+24nt" (lane2, lower band), "exon11 +intron11 bleeding" (lane3), 
"exon11+exon12" (lane 4, upper band); and a new isoform: "-exon11" (lane 4, 
lower band). But it does not rule out the presence of "+69-24" and "-69-24", since 
the competition for the same set of primers by a more dominant variant ("-69+24") 
may mask the weakly expressed variants. 
c) Demonstration of "+69-24" and "-69-24" transcripts and comparison of tissue 
distribution of all variants. Unique primer sets for each individual variant were 
used for PCR on thirteen different adult mouse tissues. Each specific band was 
cut out and sequenced for confirmation. The results demonstrated the presence 
of "+69-24" and "-69-24" variants in the retina (in supplement to figure b). It also 
demonstrated the ubiquity of the majority of the variants, with the exception of 
"+69+24" which was expressed in the central nervous system, the ovary, testis, 
kidney and heart but.absent in the lung, liver, thymus and spleen. Negative 
controls indicated no contamination from either the RT or the PCR reactions. 
d) Mapping of the location of primers used in b) and c) to the CPEB3 cDNA. The 
sequences of these primers were listed in table 4. CPEB3 isoforms 
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isoform 5), or "exon 11+exon 12" (figure 28, isoform 1a-1d, 2, 3, 4, and 6) for variants 
near the exon 11 region. 
Our results from RT-PCR demonstrated the presence of "+69+24", "-69+24" (figure 30b, 
lane2) in exon 5-7 region; "extended exon 11" (figure 30b, lane3), and "exon 11+ exon 
12" (figure 30b, lane4 upper band) around exon 11 region in the retina. Additionally, a 
novel CPEB3 isoform without exon 11 ("-exon 11 "), confirmed by sequencing, was also 
identified in the retina (figure 30b, lane 4 lower band). This is the first time this isoform 
has been shown. 
For the exon 5-7 region, although only two bands were detected in the RT-PCR, it was 
possible that more dominant transcripts "masked" weaker transcripts by competition for 
the same set of primers. Therefore, we designed separate sets of primers for individual 
transcripts in this region to further explore their presence or absence (figure 30d). Each 
specific band was cut out and sequenced for confirmation (data not shown). Our results 
demonstrated that the "+69-24" and "-69-24" variants were indeed present in the retina 
(figure 30c). 
We also collected multiple tissues to test all known transcripts for possible tissue 
specificity. Of all the variants tested, the majority did not appear to differ with respect to 
tissue distribution. The only exception was the "+69+24" variant, which was strongly 
expressed in the central nervous system, ovary, testis, kidney and heart, but not in the 
thymus, spleen, lung or liver (figure 30c). 
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4) Localization of CPEB3 mRNA within the retina: the CPEB3 transcripts are 
expressed predominantly in the retinal ganglion cell layer 
With the aid of In situ hybridization, we identified which types of cells in the retina 
express CPEB3 mRNA in the P60 mouse. To ensure specificity, probes were designed 
in a region where little homology was found between CPEB3 and the other CPEBs. A 
sense probe at the exact location was used as a negative control. The primers used to 
generate the sense and antisense probes were listed in table 3. Our results 
demonstrated that CPEB3 is localized predominantly in the RGC layer, and to a less 
extent, in the inner margin of the INL (figure 31). CPEB3 appeared to be present in the 
plexiform layers as well, but no synaptic structure was identifiable due to the limitation on 
the resolution of in situ hybridization technique. 
5) CPEB3 transcription is up-regulated during postnatal development of the retina 
To investigate the expression of CPEB3 during development, real-time PCR was used to 
evaluate the relative amount of CPEB3 mRNA in the retinas of mice at different ages. An 
amplicon of 79 nt spanning exon 4 and exon 5 was amplified, and was inclusive of all 
CPEB3 isoforms (table 8). Our results (figure 32) demonstrated that the overall 
transcription level of CPEB3 was up-regulated thoughout postnatal development in the 
retina. A significant increase in the level of CPEB3 transcripts was seen around the eye 
opening time (P14). The level of CPEB3 transcripts continued to increase after eye 
opening, and until adulthood (P60). Since the CPEB3 primer set for real-time PCR 
matched all known CPEB3 isoforms, the data did not distinguish each transcript variant. 
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Figure 31. Localization of CPEB3 mRNA in the retina 
14um thick cryostat sections of P60 mouse retina were used for in situ hybridization of 
CPEB3. The probes were designed in a region with no significant homology to the other 
three CPEBs to ensure probe specificity. The expression of CPEB3 mRNA was 
predominantly located in the RGC layer and to a lesser extent, the INL. The IPL 
appeared to be labeled as well, but the synaptic structures could not be recognized due 
to the limitation on the resolution of in situ hybridization techniques. Scale bar 
represented 50 11m. ONL: outer nuclear layer; OPL: outer plexiform layer; INL inner 












Figure 32. Developmental pattern of CPEB3 mRNAs 
CPEB3 mRNA was up-regulated during postnatal development. Seven post natal ages 
flanking the eye-opening event were used for this study. For each sample the level of 
CPEB3 mRNA was normalized to that of 18S mRNA in the exact same sample. The 
relative fold changes were acquired by calibrating the older ages to age. All experiments 
were repeated three times. Statistically significant differences were indicated between 
two bracketed ages (p<=0.05). The Anova procedure Tukey's Studentized Range (HSD) 
was used. For each age, the number of samples n>=6. Error bars represented the 
standard deviation. The asterisk indicated the approximate time of eye-opening. The 
results demonstrated that CPEB3 was significantly up-regulated in the retina during 
postnatal development and reached its maximum in adult mice (day 60). 
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Figure 32 
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6) Localization of CPEB3 protein: CPEB3 protein is predominantly expressed in the 
inner retina 
To confirm the expression pattern of CPEB3 mRNA and to better define the cell types 
containing CPEB3 protein, we performed fluorescence immunocytochemistry using an 
antibody to CPEB3 (figure 33, 34). A similar pattern was observed as for the in situ 
hybridization: CPEB3 protein was predominantly expressed in the retinal ganglion cell 
layer, and to a less extent, within the inner boundary of the INL (figure 8). To define the 
type of cells which express CPEB3 we used double immunolabeling with cell-type 
specific markers, specifically, ganglion cell specific marker MAP1 a (Tucker and Matus 
1988; Okabe et al. 1989), or cholinergic amacrine cell marker ChAT (Eckenstein and 
Thoenen 1982; Tumosa et al. 1984; Schmidt et al. 1985; Pourcho and Osman 1986; 
Tumosa and Stell 1986; Voigt 1986), in combination with CPEB3. Confocal images 
indicate that most CPEB3-postive celis in RGC layer are ganglion cells (figure 33), and a 
few are displaced amacrine cells (figure 34). 
Both the inner plexiform layer and outer plexiform layer appeared to be immunopositive 
for CPEB3 labeling (figure 33, 34). The pattern of CPEB3 in the IPL was diffuse 
compared to the more laminar pattern of CPEB1 in the same layer (figure 22, 23). 
Within the location of immunogen for CPEB1 antibody (167-184 a.a.) and that of CPEB3 
antibody (between 300-400 a.a.), little homology between CPEB1 and CPEB3 was 
found. Therefore, cross-reactivity between the two antibodies seemed highly unlikely. 
The identity of synaptic structures in the plexiform layers was not determined. An 
extensive characterization with double and triple labeling methods was beyond the 
scope of this dissertation. 
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Figure 33. Localization of CPEB3 protein- with MAP1 a 
Double-immunofluroscence of CPEB3 and MAP1 a on P60 mouse retina indicated that 
the majority of CPEB3 positive celis in the retinal ganglion celi (RGC) layer were also 
MAP1a positive. MAP1a has been demonstrated as a marker for retinal ganglion celis. 
The absence of labeling when CPEB3 antibody was pre-adsorbed with recombinant 
CPEB3 protein (right upper panel) demonstrated the specificity of the CPEB3 antibody. 
Images were acquired with the aid of an Olympus confocal microscope. The scale bar 




Figure 34. Localization of CPEB3 protein- with ChAT 
Double-immunofluorescence of CPEB3 and ChAT on p60 mouse retina indicated that a 
few CPEB3 positive cells in RGC layer were also ChAT positive, as indicated with the 
arrows. ChAT is a marker for cholinergic amacrine cells and displaced amacrine cells. 
This suggested that a few CPEB3 positive cells in RGC layer were displaced amacrine 
cells. The size of such cells was usually smaller than those staining positive for both 




7) Developmental regulation of CPEB3 protein: CPEB3 protein is up-regulated 
during postnatal development of the retina 
Our next aim was to investigate the relative abundance of CPEB3 protein in the 
developing retina with the aid of Western blots. To examine antibody specificity we used 
a recombinant CPEB3 protein to pre-adsorb the antibody. This served as a negative 
control. The GST-CPEB3 fusion protein induced in E. coli was visualized on SDS-PAGE 
gel (figure 35a). The induced protein was then purified by immunoprecipitation, and 
subjected to mass spectrometry for identification. MS results (figure 35b) confirmed its 
identity as CPEB3. The fusion protein was then used as a blocking reagent for the 
CPEB3 antibody. 
We identified four immunopositive bands in Western blots that were diminished by pre-
adsorption (figure 35c). These included bands with relative molecular weight of -130kD, 
75kD, 67kD and 62kD. The 75kD band appeared to be the mature form based on its 
predicted size in the database. Our results indicated that this band increased 
significantly in intensity during postnatal development of the retina. This was consistent 
with data demonstrating a postnatal increase in CPEB3 mRNA (figure 32). The other 
bands may represent isoforms from other transcript variants present in the retina, 
breakdown products, or other CPEB3-related products. One band (-11 Ok D) appeared 
not to be blocked by the pre-adsorption of antibody with fusion protein. The unblocked 
band may be a problem when the same antibody was used for immunohistochemistry; 
however this issue was resolved by using pre-adsorbed antibody as a negative control 
for the immunocytochemistry, which showed no signal. Statistical analysis (ANNOVA T 
tests) indicated that there was significant increase in the level of CPEB3 (75kD) from P1 
and P7 to P12 (figure 35d). 
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Figure 35. Developmental pattern of CPEB3 proteins 
CPEB3 protein was up-regulated during the postnatal development of the retina. 
a) The expression of recombinant CPEB3 protein. An extra band of the expected 
size for GST-CPEB3 fusion protein appeared in IPTG- induced sample (+) 
compared to non-induced sample (-). 
b) The extra band in samples induced for recombinant CPEB3 was cut out and 
subjected to mass spectrometry. The pattern from MS confirmed that this band 
was recombinant CPEB3 protein. 
c) CPEB3 western blot on retinal samples from mice of different postnatal ages. 
The results showed that there was an increase in the amount of CPEB3 protein 
during the development (75kD band). This band disappeared when the antibody 
was pre-adsorbed with the recombinant CPEB3 antibody (the two lanes to the 
right). Another two bands at -130kD and -65kD respectively also disappeared 
when CPEB3 antibody was pre-adsorbed with recombinant CPEB3 proteins, 
suggesting that they represent different forms of CPEB3. The up-regulation of 
CPEB3 protein during development is consistent with that of CPEB3 mRNA. 
GAPDH was used as a loading control. 
d) Quantification of the level of CPEB3 protein during development. Significance 
up-regulation was observed between two bracketed age set: P1 to P12, and P7 
to P12 (p<=O.05). Each CPEB3 band was normalized to the GAPDH band in the 
same sample. Annova was used for statistics on three biological repeats. Error 








.... .... UG 

















The level of CPEB3 protein (-75kD) 
during development 
Pl P1 P12 Pl_ Pl_ PlO P60 
I 
J 
In summary, our study identified several CPEB3 isoforms (both mRNA and protein) from 
the NCBI and Swiss-ProtlTrEMBL databases. A novel CPEB3 isoform was identified 
experimentally for the first time. Among the previously known isoforms and the isoforms 
we identified, only one had discriminative tissue distribution. Our data also 
demonstrated the presence of CPEB3 in the retina. CPEB3 was predominantly 
expressed in the inner retina. Both the mRNA and the protein levels of CPEB3 were up-
regulated in the retina during postnatal development. 
3. CPEB1-4 comparisons 
Four CPEB paralogs, CPEB1-4, have been identified in rodent. Current studies on 
cytoplasmic polyadenylation are predominantly focused on CPEB1, whereas the 
mechanisms of CPEB1 are yet to be fully established. Very little is known with regard to 
CPEB2-4. We were able to draw some comparison among the four CPEBs based on 
our study within the retina. 
1) Sequence comparison of CPEB1-4 
Some comparisons have been made among CPEB1-4 in the literature with regard to the 
RNA recognition domain (Theis et aI2003). In our study we performed a comprehensive 
sequence alignment of those four. Since CPEB1 is more distant to CPEB2-4 in the 
family tree, therefore, we first aligned CPEB1-4 (figure 36). Then, in order to better 
reveal the differences and similarities between CPEB2-4, we aligned these three 
separately (figure 37). 
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Figure 36. Sequence alignment of CPEB1-4 proteins 
Sequence alignment was performed using ClustalW. Sequences with the following 
accession numbers were used: CPEB1: NP _031781.1; CPEB2: NP _787951.1; CPEB4: 
NP _938042.2; CPEB4: NP _080528.2. The alignment demonstrated higher homology in 
the C-terminus compared to the N-terminus. CPEB1 had more variance from CPEB2-4 
across the whole sequence. Asterisk represented 100% identity; colons represented 






































































































































































Figure 37. Sequence alignment of CPEB2-4 proteins 
Sequence alignment was performed using ClustalW. Ref Seq sequences with the 
following accession numbers were used: NP _787951.1 for CPEB2, NP _938042.2 for 
CPEB3, and NP _080528.2 for CPEB4. Sequences highlighted in blue were unique to 
CPEB3, and sequences highlighted in yellow were highly conserved among CPEB2-4. 
Asterisk indicated 100% conservation; colon indicated substitution with a similar amino 
acid; period indicated substitution with a distinct amino acid. 
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Figure 37 
CPEB3 -- ---- ------ -- ---- -------- ---- ---- ---- ----- -MQDDLL 
CPEB2 - - ---- ------------ ---- - - -------------- ---- - -- - - ---
CPEB4 MGDYGFGVLVQSNTGNKSAFPVRFHPHLQPPHHHQNATPNPAAFINNNTA 50 
CPEB3 MDKSKT------------- PEPGAAEAPST 42 
CPEB2 -- ---- ------ -- ---- - --- -- ------ ---- - ------------ -- -
CPEB4 ANGSSAGSAWLFPAPATHNIQDEI LGSEKAKSQQQEQQDPLEKQQLS PSP 100 
CPEB3 PLSSEI PKPEDSSAVPALSPASAPPAPNGPDKMQMESPLLPGLSFHQPPQ 92 
CPEB2 ---------- ---- -- -- - --- ------------ --- -------------
CPEB4 GQEAGILPETEKAKAEENPGDSSSENSNGKEKLRIESPVLTGFDYQEATG 150 
C PEB3 QPPPPQE PTAPGASLS---- PSFGSTWSTGTTNAVEDSFFQG- ---- ITP 13 3 
C PEB2 - ------------ - - - - ----- ---- -------- --- - ----- -------
CPEB4 LGTSTQPLTSSASSLTGFSNWSAAIAPSSSTIINEDASFFHQGGVPGASA 200 
CPEB3 VNGTMLFQNFPHHVNPVFGGTFSPQIGLAQTQHHQQPPPPAPQPPQPAQP 183 
CPEB2 -- --------- --- -------- ---MNLPO----QQPPAAAPOQPQSRRS 21 
C PEB4 NNGALLFQNFPHHVSPGFGGSFS PQIGPLS---- - -- - QHHPHHPH- FQH 241 
C PEB3 PQAQPSQQRRS PAS PSQAPYAQRSAAA YGHQPIMT--SK 231 
C PEB2 PVSPQLQQQHQAAA- --AAFLQQRNSYNHHQPLLK --QS P------ - --- 56 
C PEB4 HHSQHQQQRRS PAS PHPP PFTHRSAAFNQLPHLANNLNKPPSP--- - - -- 284 
, * 
CPEB3 AiE;lil~i1i:lts4WNTHQSV----NAAWSAPSNPWG--GLQAGRDPRRA VGV 275 
CPEB2 - - ---- -----WSNHQ-- ----NSGWGTASMSWG--AMHG-RDHRRSG-- 84 
CPEB4 -- ---- --- --WSSYQS PSPTPSSSWS PGGGGYGGWGASQGRDHRRGLN- 322 
CPEB3 GVGVGVGVPSPLNPISPLKKPFSSNVIAPPKFPRAAP-LTSKSWMEDNAF 324 
CPEB2 - -- -NMGIPGTMNQISPLKKPFSGNVIAPPKFTRSTPSLTPKSWIEDNVF 130 
CPEB4 ------GGIT PLNS IS PLKKNFASNH IQLQKYARPSSAFAPKSWMEDSLN 366 
CPEB3 RTDN-GNNLLPFQDRS-RPYDTFNLHSLENSLMDMIRTD-HEPL 371 
CPEB2 RTDNNSNTLLPLQVRSSLQLPAWGSDSLQDSWCTAAGTSRIDQDRSRMYD 180 
CPEB4 RADN-- -- I FPFPERP-- --RTFDMHSLES---- ------------- --- 388 
CPEB3 GRMGINFHHPGTDNlMAL 418 
CPEB2 SLNMHSLENSLI DIMRAEHDPLKGRLSHHPGTDNLLMLN--- -----GR 222 
CPEB4 -- -- -- ---SLI DIMRAENDSI KGRLNYSYPGSDSSLLINARTYGRRRGQ 429 
CPEB3 SSLFPFEDAFLDDSHGDQA-LSSGLSSPT-- RCQNGERVERYSRKVF'JGG 465 
C PEB2 SSLFPI DDSLLDDGHSDQVGVLNS PTCYS--AHQNGERIERFSRKVFVGG 270 
C PEB4 SSLFPMEDGFLDDGRGDQP- LHSGLGS PHCFTHQNGERVERYSRKVFVGG 478 
* *""** .. • . w** . ** . . . . . 
CPEB3 LPPDIDEDEITASFRRFGPLWDWPHKAE~KSYFPPKGYAFLLFQEESSV 515 
CPEB2 LPPDIDEDEITASFRRFGPLWDWPHKAESKSYFPPKGYAFLLFQEESSV 320 
CPEB4 LPPDI DEDEITAS FRRFGPLIVDWPHKAESKSYFPPKGYAFLLFQDESSV 528 
**., ** ~ ... * ... ~ ***"' ..... **; .. . "**** .. '" ~ ~* .. ,..- ,-... ""..,**. *, .. ... **** , , 
CPEB3 QA;,T DACLEEDGKLYLC'JSSPTIKDYP'iQ: RPw"NLSDSDFVMDGSQPLDP 565 
CPEB2 QALI DACIEEDGKLYLCVSSPTIKDKPVQI RPWNLSDS DFVMDGSQPLDP 370 
CPEB4 QALIDACIEEDGKLYLCVSSPTIKDKPVQIRPWNLSDSDFVMDGSQPLDP 578 
615 
CPEB2 RKTIFVGGVPRPLRAVELAMIMDRLYGGVCY AGI DTDPELKY PKGAGRVA 420 
CPEB4 RKTI FVGGVPRPLRAVELAMIMDRLYGGVCYAGI DTDPELKY PKGAGRVA 628 
CPEB3 FSNQQSYlAAISARFVQLQHNL LD"'JEVKHVLDDQM:: f::vG;'''CGGK 665 
CPEB2 FSNQQSY IAAISARFVQLQHGDI DKRVEVKPYVLDDQMCDECQGARCGGK 470 
CPEB4 FSNQQSYIAAISARFVQLQHGEIDKRVEVKPYVLDDQLCDECQGARCGGK 678 
ePEB3 FAPFFChN?TCI..,Q'fi'CE:yr:WASIHSRAGEEFHY.P::....VKE· "::P"P. ,,;FP. 715 
CPEB2 FAPFFCANVTCLQYYCEFCWANIHSRAGREFHKPLVKEGADRPRQIHFRW 520 
CPEB4 FAPFFCANVTCLQYYCEYCWAAIHSRAGREFHKPLVKEGGDRPRH1SFRW 728 
CPEB3 S 716 
CPEB2 N 521 
CPEB4 N 729 
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Poly- Q track 
Phosphorylation site / SA track 
23 a . a . 
8 a . a . (Phospho - site for CaMKlla/Sp6) 
The first RRF 
The second RRF 
The comparison clearly demonstrated that the N terminus is more diverse among the 
different paralogs. The C-terminus, where the important functional domain such as 
RNA-recognition motifs reside, is highly conserved. The C-terminus is almost identical 
for CPEB2-4 (95% identity according to figure 10); however, it varies significantly from 
the terminus of CPEB1 (45% identity according to figure 10). 
2) All four CPEBs are present in the retina 
With the aid of regular RT-PCR, we explored the presence of four CPEB paralogs in the 
retina (figure 38). Total retinal RNA from adult mice was used for the amplification. The 
primer set for each gene was designed to be exclusive of each other. Amplicons were 
separated on agarose gel. Distinct bands were cut out and sequenced to confirm the 
identity. The result demonstrated the all four CPEB mRNA are expressed in the retina. 
Due to possible differences in amplification efficiency of each primer set, this data is not 
suitable for quantitative studies, which will be obtained later using real-time PCR 
experiments (see below). 
3) Cellular localization of CPEB1-4 mRNA 
With the aid of in situ hybridization, we compared the tissue distribution of four CPEBs in 
the retina (figure 39). Each probe was specifically designed with no significant similarity 
to others. The sequences of the template for each probe were confirmed with 
sequencing analysis. In situ hybridization demonstrated a similar pattern of four CPEBs: 
predominantly expressed in the retinal ganglion cell layer; to some extent, to the inner 
layers of the inner nuclear layer. Some signal appeared to be in the inner plexiform 
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Figure 38. Presence of four CPEBs in the retina 
P60 mouse retinal total RNA was used for the RT-PCR. l3-actin was used as a positive 
control. The "-" control had all the components as l3-actin reaction except that the 
reverse transcriptase was omitted at the RT step. The primer sets for all genes were 
designed with low homology with each other or with any other genes. Each band in the 
agarose gel was cut out, purified and sequenced to confirm its identity. The results 
showed that all four CPEB homologs were expressed in the retina. This result was not 
suitable for quantification, since each set of primers may have distinct amplification 
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Figure 39. Localization of four CPEB mRNAs in the retina 
P60 slides were used for in situ hybridization. Probes for each gene were designed 
within a region that was less homologous to the other homologs or any other genes. 
The sequences of all probes were confirmed via sequencing. The results demonstrated 
that CPEB 1-4 have a similar pattern of distribution within the cellular layers of the retina: 
predominantly in RGC layer, to some extent, in the inner layers of INL. Their distribution 
in synaptic structures in the plexiform layers could not be confirmed at this point due to 
the limitation of the resolution of this technique. This result was not suitable for 
quantification analysis due to the fact that different probes may have distinct binding 
efficiencies to their complementary mRNA. Quantitative studies would be done based 






layers, although the fine synaptic structures were not distinguishable due to the 
resolution of this technique. This data is not suitable for quantitative comparisons since 
different probes may have different efficiencies for hybridization. Quantitative analysis 
will be done based on real-time PCR data. 
4) Developmental regulation of CPEB1-4 
The expression pattern of each CPEB during the development was explored using real-
time PCR methods. Total retinal RNA from each age was used in combination with 
gene-specific primer sets and gene-specific FAM-Iabeled probes. The level of each 
gene was normalized to the level of 188 in the same sample. Relative fold changes 
were acquired by calibrating transcript levels of each age to the age of P1. Different 
developmental expression patterns were revealed for the four genes (figure 40): For 
CPEB1 and CPEB3, significant up-regulations were observed throughout development. 
Both increases started early in development and continued until adulthood. CPEB4 was 
mildly up-regulated during development; while CPEB2 stayed rather constant throughout 
development. 
For CPEB1 and CPEB3, the mRNA in P12 was increased significantly compared to P1 
or P7. The level of mRNAs between P12, P14 and P16 was more like a plateau, with no 
significant increase between those three ages. Another significant increase occurred in 
P30, compared to P14 or P16 for CPEB1 and CPEB3, respectively. For CPEB4, a 
significant increase was found in P12 compared to P1; no significant changes were 
found between P12, P14 and P16; the level of CPEB4 was increased significantly further 





Figure 40. Four CPEBs - trends in development 
Total RNA from the retinas of postnatal day1, 7,12,14,16,30, and 60 mice which were collected at the same time of the day was 
used for real-time PCR assays. The combination of gene-specific primers and FAM-Iabeled gene-specific probes ensured high 
specificity. 18S was used as an endogenous control. The relative fold changes were acquired by calibrating all the older ages to 
age P 1. Each age had 6-10 animals. The Anova procedure, Tukey's Studentized Range (HSO) was used for statistics. Error bars 
indicated standard deviation (SO). Significant changes were demonstrated between each two bracketed ages (p<=0.05). The results 
demonstrated significant increases of CPEB1 and CPEB3 mRNA during post-natal development. CPEB4 had a slow increase; while 
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CPEB 1, CPEB3, and CPEB4 from the newborns to the adults were 6-fold, 13-fold, and 
2.5-fold respectively. 
5) Relative abundance of four CPEBs 
Comparisons across genes were derived from the real-time PCR data. Relative levels of 
mRNA for different genes were acquired by simply normalizing levels of each gene to 
that of 18S in the same sample. Strikingly, the most abundant gene among four CPEBs 
was not the overtly regulated ones. The most abundant gene among all four was 
CPEB4. The level of CPEB3 was the second most abundant. Both CPEB3 and CPEB4 
were more than one magnitude, sometimes two magnitudes more abundant than 
CPEB1 and CPEB2. CPEB1 was less abundant than CPEB2 in the early ages, but then 
surpassed CPEB2 as it was up-regulated in the later ages (figure 41). The level of 
CPEB2 was consistently low. 
In summary, our data demonstrated that all four CPEBs were expressed in the retina. 
The mRNAs of all four CPEBs were predominantly localized in the retinal ganglion cell 
layer. The transcription of CPEB1, 3 and 4 was up-regulated during postnatal 
development; while CPEB2 stayed rather constant. The relative abundance at any given 
age was CPEB4 > CPEB3 > CPEB2 or CPEB1. In early ages (P1 and P7), CPEB2 was 
more abundant than CPEB1, in older ages (P30 and P60), CPEB1 surpassed CPEB2. 
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Figure 41. Comparison of the relative abundance of four CPEBs 
Total RNA from the retinas of postnatal day1, 7, 12, 14, 16, 30, and 60 mice which were collected at the same time of the day was 
used for real-time PCR assays. The combination of gene-specific primers and FAM-Iabeled gene-specific probes ensured high 
specificity. 18S was used as an endogenous control. The relative fold changes were acquired by calibrating all the older ages to 
age P1. Each age had 6-10 animals. The Anova procedure, Turkey's Studentized Range (HSO) was used for statistics. Error bars 
indicated standard deviation (SO). Significant differences were indicated between each two bracketed ages (p<=0.05). The results 
demonstrated that of any given age, CPEB4 mRNA was the most abundant; CPEB3 was the second most abundant. CPEB1 mRNA 
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1000 l CPEB2 4.9 3.2 1.3 1.1 1.7 1.6 0.6 
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CHAPTER V 
CONCLUSIONS AND DISCUSSION 
In conclusion, these studies demonstrate that all four CPEBs are present in the mouse 
retina. The spatial distribution patterns of the transcripts of four CPEBs are somewhat 
different but all four are predominantly localized in cells of the inner retina. The temporal 
expression patterns, in particular are quite different for the four CPEBs. Thus, CPEB1 
and CPEB3 are up-regulated in the retina during development and reach a maximum in 
adulthood; CPEB4 is up-regulated to a lesser extent throughout this period; while 
CPEB2 stays rather constant. These different spatio-temporal patterns may reflect their 
as yet undiscovered roles in the retina. 
In this study we also screened for potential mRNA targets of CPEB1, using a 
combination of computational programming and wet-lab experiments. Some of these 
mRNAs acquired elongated poly(A) tails during the earliest periods of postnatal 
development. In addition, multiple CPEB3 transcript variants and CPEB3 protein 
isoforms were identified from an analysis of the national databases (NCBI, Swiss-
ProtfTrEMBL). One of these isoforms was found to have a discriminative tissue 
distribution. Additionally, a novel transcript of CPEB3 was identified through these 




1. Distinct expression patterns and sequence discrepancies indicate functional 
divergences between members of the CPEB family 
The expression patterns of four CPEBs in the retina demonstrated some uniqueness for 
each paralog. Although in situ hybridization data showed similar patterns of the four, 
localization data from immunohistochemistry microscopy refined the differences between 
the patterns of CPEB1 and CPEB3 in the inner plexiform layer. CPEB1 had a laminar 
structure, while CPEB3 was more diffusive. Developmental studies further compared 
the regulation of four CPEBs postnatally. From newborn to adult, CPEB1 and CPEB3 
was up-regulated 6-13 fold, respectively; CPEB4 increased by about 1.5 fold, whereas 
CPEB2 stayed constant. Both the spatial and temporal patterns of CPEBs in the retina 
revealed some degree of diversity. Similarly, distinct expression patterns of CPEB1-4 
were also reported in the hippocampus (Theis et al. 2003; Huang et al. 2006). 
Sequence comparisons demonstrated that CPEB1 is distant from CPEB2, 3 and 4. The 
highly conservative C- terminus of CPEB1 had merely 45% identity to the other three. 
The RNA recognition motifs between CPEB2, 4 and the prototypical CPEB3 are 97-99% 
identical, indicating high degree of overlapping with respect to substrate specificity. 
However, their N-termini where regulational domains such as phosphorylation sites 
reside are dramatically variable. 
The accumulative evidence on the structure, distribution, and regulation of CPEBs may 
dictate their functional distinctness. Such differences may embody multiple aspects 
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such as spatial and temporal availability, substrate specificity, responses to discrete 
stimuli, and signaling cascades they are associated with. 
With those notions made, four CPEBs share some common features both structurally 
and functionally. Current knowledge on CPEB1, which has been studied most 
extensively, may be applicable to speculate on CPEB2-4 when appropriate to broaden 
our view. 
2. CPEBs and the inner retina 
1) CPEBs are expressed in the RGC layer, the INL, and the IPL. 
All four CPEBs are present in the inner retina. In situ hybridization indicated that 
transcripts of all four CPEBs are predominantly expressed in the retinal ganglion cell 
layer, and to some extent, in the inner nuclear layer. Immunocytochemistry with 
available antibodies to CPEB1 and CPEB3 showed positive lableling in retinal ganglion 
cells and amacrine cells. Only a subset of ganglion cells are positive for CPEB1 or 
CPEB3, since not all MAP1 positive cells are CPEB1 positive or CPEB3 positive. 
Similarly, only a small population of cholinergic amacrine cells is CPEB3 or CPEB1 
positive. 
Immunofluorescence labeling of fixed tissue sections also strongly demonstrated the 
presence of CPEB1 and CPEB3 within the inner plexiform layer. CPEB1 labeling was 
associated with laminar structures in the inner plexiform layer, whereas CPEB3 labeling 
demonstrated a more diffuse pattern. The CPEB1 immunopositive laminae did not 
appear to co-localize with ChAT immunolabeling. The close juxtaposition of the CPEB1 
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positive laminae to ChAT positive laminae suggested that CPEB1 laminae may reside in 
sublamina a and sublamina b of the IPL. 
2) The identities of the CPEB positive cells and/or synapses need to be further 
characterized. 
The subtypes of the CPEB1 or CPEB3 positive ganglion cells were not specifically 
identified in our study but should be pursued in future studies. About 11 morphologically 
distinct subtypes of RGCs with distinct dendritic architectures are known to be present in 
the mammalian retina (Cajal 1893; Yamagata and Sanes 1995a; Yamagata and Sanes 
1995b; Rodieck 1998; Rockhill et al. 2002). More than a dozen of subtypes of amacrine 
cells have been described (Kolb 1997) based on the diameter of their dendritic field and 
the sublamina where their synapses are located. The number of types of amacrine cells 
continues to grow as techniques such as intracellular physiological recording, 
immunohistochemistry, and biochemical methods became available (Casini et al. 1995; 
Crooks and Kolb 1992; Kolb et al. 1992; MacNeil and Masland 1998). 
Immunohistochemistry combining CPEB antibody with the subtype-specific antibodies 
can help to pinpoint the identity of the CPEB positive cells. 
Similarly, the identity of the CPEB positive structures in the inner plexiform layer can be 
addressed. The IPL was divided into five equal-thick strata (CajaI1892) into which 
synapses between bipolar, amacrine and ganglion cells can be assigned. A sublaminar 
division was later applied to the IPL in superimposition to Cajal's five strata (Famiglietti 
and Kolb 1976): sublamina a corresponds to strata 1-2; sublamina b corresponds to 
strata 3-5. Distinct subtypes of RGCs maintain their functional specificity by forming 
synaptic connections with appropriate pre-synaptic bipolar cells or amacrine cells at 
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distinct sublaminae of the IPL. Many amacrine cells make their contacts with RGCs in a 
single stratum in the IPL, but some are bi-stratified or even tri-stratified (Strettoi et al. 
1992; Zucker and Ehinger 1998; Loeliger and Rees 2005; Mojumder et al. 2008). 
Further characterization need to be done to identify CPEB structures in the IPL with the 
assistance of cell-type specific markers. 
3) The laminar structure of CPEB1 labeling in IPL may be related to ON and OFF 
pathways 
One of the basic principles of the visual signal processing in the visual system is the 
separation of ON and OFF pathways at virtually all levels of the visual pathway. The ON 
pathway responds to onset of a light stimulus; while the OFF pathway to the termination 
of a light stimulus. The separation of ON pathway and OFF pathway starts at the first 
synaptic contact - the bipolar cell level in cone-driven systems, and at the second 
synaptic contact - amacrine cell level in rod-driven system. They remain separated at 
the retinal ganglion cell level, and in upper levels of the visual system such as the lateral 
geniculate nucleus (LGN) and the visual cortex. Cone ON-bipolar cells are thought to 
exclusively express metabotropic glutamate receptor 6 (mGluR6), and form synaptic 
contacts with ON ganglion cells in sublamina b of the IPL; whereas OFF bipolar cells 
form synaptic contacts with OFF ganglion cells in sublamina a. 
At least two laminar structures in the IPL for CPEB1 labeling were distinguishable. They 
appeared to be non-cholinergic synapses since they did not co-localize with ChAT 
labeling. But they appeared to be in close proximity of the two ChAT positive laminar 
structures, which are known to reside at strata 2 (within sublamina a) and strata 4 (within 
sublamina b) respectively (Kang et al. 2004). It is highly likely that the two CPEB1 
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positive lamina structures are located in sublaminar a and sublamina b, respectively, 
which will make a plausible inference that CPEB1 in these two synaptic bands contribute 
to OFF pathway and ON pathway. 
4) The spatial patterns of CPEBs resemble that of some synaptic molecules which 
are potential targets of CPEBs 
Although the significance of the distribution pattern of CPEBs in the retina is yet to be 
delineated, we realized that such expression patterns resemble the known expression 
patterns of some synaptic molecules which are potentially targets of CPEB based on our 
investigation. Such mRNAs include: CaMKIl (Liu et al. 2000), NR1, NR2A-D (Grunder et 
al. 2000b; Araki and Hamassaki-Britto 2000), GluR1, and GluR2 (Grunder et al. 2000a; 
Hack et al. 2001; Kamphuis et al. 2003; Dijk and Kamphuis 2004). 
Immunohistochemistry in combination with in situ hybridization can determine whether 
these mRNAs co-localize with CPEBs in the retina. This may help to clarify the 
relationships between these molecules and CPEB. 
3. CPEB3 and the outer retina 
One of the differences between the spatial patterns of CPEB3 and CPEB1 was that 
CPEB3 was present in the outer plexiform layer at a more profound level (figure 22, 23, 
33, 34). This may indicate a distinct aspect of the function of CPEB3 in the outer 
plexiform layer. Although we did not determine whether CPEB3 is localized in the pre-
synaptic or post-synaptic compartment due to the lack of a good post-synaptic marker 
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(Aartsen et al. 2006), further investigation on the subcellular location of CPEB3 is 
necessary for delineating its role in outer plexiform layer. 
The outer plexiform layer possesses some degree of plasticity for structural and 
functional remodeling. Ectopic synaptogenesis was observed in retinas undergoing 
degeneration. For instance, the retina with mutations for presynaptic cytomatrix protein 
Bsn, calcium binding protein Cabp4, or the calcium channel protein, Cacna1f, 
manifested impaired synaptic transmission. Along with the structural and functional 
defects, horizontal cells and bipolar cells grew their neurites into the outer nuclear layer, 
an area usually devoid of synapses, and formed synaptic contacts with the 
photoreceptor cells (Chang et al. 2006; Mansergh et al. 2005; Dick et al. 2003; 
Haeseleer et al. 2004). Such ectopic synapses were formed de novo, long lasting and 
capable of sustained neurotransmitter release (Specht et al. 2007). Similar remodeling 
in the outer plexiform layer has been reported in other types of genetically modified mice 
with photoreceptor degeneration (Peng et al. 2000; Strettoi and Pignatelli 2000; Claes et 
al. 2004; Strettoi et al. 2004; Jansen and Sanyal 1992; Peng et al. 2003). It was also 
observed under pharmacological conditions (Wang et al. 2008) or pathological 
conditions such as stroke, AMD or normal aging retina (Eliasieh et al. 2007; Sullivan et 
al. 2007). 
The mechanism underling such synaptic plasticity is yet to be unraveled. It is not known 
whether the retina recapitulates the mechanism from other parts of the CNS, such as the 
hippocampus and the visual cortex, where CPEB mediated local translation plays a key 
role in the L TP or LTD. One possible theory is that CPEB3 expressed in the outer 
plexiform layer is involved in processes related to synaptic activity. Mutant or 
pathological models can be used to determine whether there is an association of CPEB3 
with synaptic remodeling in the outer plexiform layer in the retina. 
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4. CPEB1, CPEB3, CPEB4 and synaptogenesis 
Three CPEBs, CPEB1, 3, and 4 were up-regulated during the postnatal development of 
the retina. The significant increases occur between P1 and P12, as well as between 
P16 to P60. The increases of these three CPEBs were less profound around eye-
opening time (P12 to P16). The enhanced expression of these genes during 
development, both at transcriptional level and translational level, may be a good 
indicator for their possible involvement in synaptogenesis. 
It is well established that the mammalian retina is premature at birth. Mouse retina 
reportedly matures on postnatal day 41 (Blanks and Bok 1977). The ganglion cell layer 
and the inner plexiform layer are recognizable at the time of birth, but the remainder of 
the retina is yet to be fully developed. The synaptogenesis in the inner plexiform layer 
(IPL) starts at day 3 and slows down precipitously at day 15 (around the time of eye-
opening (Fisher 1979b; Fisher 1979a). Robust glutamatergic synaptic formation occurs 
in the second postanatal week, and synaptic sublamina in the inner plexiform layer 
becomes visible on day 12 (Sherry et al. 2003). Synaptic connections in OPL begin to 
develop on day 3 and are well established by day 12, the time when the first light 
response was recordable as ERG (Rich et al. 1997). Synaptic contacts between 
photoreceptors and bipolar cells in the OPL, and between bipolar cells and ganglion 
cells in the IPL are established slightly before eye opening (Marquardt and Gruss 2002). 
The up-regulation of CPEB 1, CPEB3, and CPEB4 during the first two weeks is 
concurrent with the process of synaptogenesis, which prompts the likelihood that CPEBs 
are either of key significance to the process of synaptogenesis, or their expression is 
regulated as a consequence of synapse formation. Eye opening may dampen the 
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enhanced expression of CPEBs. Future investigations on the interaction of CPEB 
proteins and synaptic mRNAs may be devoted to synaptic molecules such as GluR2 
mRNA, a known target of CPEB3. 
AMPAR is known for its key role in fast synaptic transmission. The expression of GluR 
2/3 and 4 before the emergence of synaptic transmission indicated a role of AMPAR in 
the establishment of retinal circuitry (Grunder et al. 2000a; Chang and Chiao 2008). The 
onset and regulation of GluR2 expression in the retina is in accordance with the process 
of synaptogenesis: starts early in the postnatal period, and reaches a peak before eye-
opening (Johansson et al. 2000; Grunder et al. 2000a). In the inner plexiform layer, the 
pattern of GluR2 expression changes from a disoriented pattern at birth to a laminated 
pattern prior to eye-opening (Johansson et al. 2000), a manifestion of a reorganization of 
synaptic circuits. 
Synaptogenesis in early development is activity-dependent (Wong and Ghosh 2002). 
The formation of synaptic contacts requires the mobility of dendritic structures regulated 
by spontaneous glutaminergic transmission. The rate of dendritic mobility was 
decreased by antagonists of both NMDA receptors and non-NMDA glutamate receptors 
(Wong et al. 2000). In the long term plasticity in the hippocampus and the visual cortex, 
NMDAR activation results in CaMKlla-mediated delivery of AMPAR to the synaptic 
membrane for enhanced synaptic efficacy, and CPEB1 mediates rapid local translation 
of CaMKlla mRNA in active synaptic sites. In the hippocampus, under a different 
stimulus - kainate induced seizure, CPEB3 regulates the translation of GluR2 mRNA 
(Huang et al. 2006). If similar machinery is harnessed for synaptogenesis, then one may 
relate such key molecules to CPEB. The expression pattern for CPEB3 presented here 
is similar to the pattern for retinal GluR2 (Dijk and Kamphuis 2004; Grunder et al. 2000a; 
Hack et al. 2001; Hamassaki-Britto et al. 1993; Kamphuis et al. 2003). Both are 
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stimulus - kainate induced seizure, CPEB3 regulates the translation of GluR2 mRNA 
(Huang et al. 2006). If similar machinery is harnessed for synaptogenesis, then one may 
relate such key molecules to CPEB. The expression pattern for CPEB3 presented here 
is similar to the pattern for retinal GluR2 (Dijk and Kamphuis 2004; Grunder et al. 2000a; 
Hack et al. 2001; Hamassaki-Britto et al. 1993; Kamphuis et al. 2003). Both are 
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expressed in the same type of cells, and both are up-regulated in the first two weeks. 
Since CPEB3 protein becomes phosphorylated at Serine 197 in activated synaptosomes 
(Munton et al. 2007), a determination of the phosphorylation status of CPEB3 at each 
age would be useful to further establish the relationship of GluR2 and CPEB3. 
Manipulation of CPEB3 expression in vivo, including the use of knockout mice, could be 
used to advance the exploration of the role of CPEB3 in the retina. MAPK, BDNF/trkB, 
and certain cytoskeletal proteins are involved in synatogenesis as well (Job and 
Lagnado 1998; Schmitz et al. 1993; Oliveira et al. 2008; Cohen-Cory and Lom 2004; Liu 
et al. 2007a). MAPK and BDNF both demonstrated elongated poly(A) tails during early 
development. Further experiments are needed to establish the relationship of their 
polyadenylation with particular CPEBs. 
In addition to GluR2, several other synaptic molecules have been reported as being 
developmentally up-regulated in the retina, such as AMPAR subunits GluR1, GluR4, 
NMDAR subunits NR1, NR2A, NR2B, and CaMKlIa (Grunder et al. 2000a; Chang and 
Chiao 2008; Xue and Cooper 2001; Xue et al. 2001). These molecules are expressed in 
a similar spatial pattern as CPEBs: in ganglion cells and amacrine cells. Additionally, 
our results on potential CPEB1 target mRNAs revealed that four out of eight genes were 
up-regulated during development: CaMKlIa (which confirms the previous finding by 
Xue), Ppp2r2b, RBP-3, and Ttr. The patterns of these genes in early development were 
similar to that of CPEB1, 3 and 4. It is yet to be determined whether any of the 
aforementioned mRNAs are suitable targets of CPEB3. Bioinformatics analysis 
screening for the U-rich hairpin loop structure in the 3' UTR of mRNAs, the binding site 
of CPEB3 protein (Huang et al. 2006) could be used to predict the suitability of the 
interaction between CPEB3 and particular mRNAs. In vivo binding assays could then be 
employed to further validate such mRNA-protein interactions (Huang et al. 2006). 
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5. CPEB1, CPEB3, CPEB4 and synaptic maturation 
Although most morphological and neurochemical properties of the retina (i.e., the 
numbers of conventional and ribbon synapses, the expression of receptors for 
neurotransmitters) have reached the adult level at the time of eye opening (Fisher 1979a; 
Sassoe-Pognetto and Wassle 1997), the maturation of synaptic function continues for 
several weeks after eye-opening. For example, the synaptic strength of the RGCs, 
measured as the frequency of spontaneous synaptic activity, was low around the time of 
eye opening, and surges around P25 both in spontaneous excitatory postsynaptic 
currents (sEPSCs) mediated by glutamate receptors and in spontaneous inhibitory 
postsynaptic currents (sIPSCs) mediated by GABAIglycine receptors (Tian and 
Copenhagen 2001). The establishment of ON versus OFF pathways and the dendritic 
pruning of the IPL occur to a large extent after eye opening. 
The dendrites of RGCs ramify throughout the INL at the early postnatal time (Oiao et al. 
2004). Over development most of those dendrites achieve stratified patterns either in 
sublamina a or sublamina b of the INL. A significant portion of this morphological 
change occurs after eye opening. The ratio of bi-stratified RGCs (respond to both ON 
and OFF stimulus) to monostratified RGCs (respond to either ON or OFF stimulus) 
declined significantly in two to three weeks after eye opening (Tian and Copenhagen 
2003). 
The dendritical pruning in the inner plexiform layer is concurrent with the maturational 
alteration of bistratified ON-OFF responsive bipolar cells to monostratified ON or OFF 
responsive cells. It is postulated that the RGCs achieve their assignment to ON or OFF 
pathways by pruning their dendrites - removing "misplaced" dendrites and limiting their 
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dendrites only in sublamina a or sublamina b. Both the alteration of ON and OFF 
pathways in AGCs and the dendritic pruning in the IPL are activity dependent. The age-
dependent decline of bistratified AGCs was completely blocked in dark-reared animals. 
Light deprivation also retarded the maturational loss of ON-OFF responsive AGCs (Tian 
and Copenhagen 2003). Similar retardation in the synaptic pruning of bistratified AGCs 
was also observed in pharmacological studies which mimic the effect of light deprivation. 
Injection of 2-amino-4-phosphonobutyrate (APB), a compound that specifically blocks 
the release of glutamate by cone-driven ON bipolar cells and rod driven bipolar cells, 
diminished the maturational stratification process of AGC dendrites (Bisti et al. 1998; 
Bodnarenko and Chalupa 1993; Bodnarenko et al. 1995). Such delays in alteration of 
ON and OFF pathways and dendritic refinement elicited by light deprivation were 
reversible both in young and adult animals, however, the time course of such recovery is 
age-dependent, with younger animals requiring longer time for recovery (Tian and 
Copenhagen 2001). 
The mechanism underlying the activity-dependent maturation of ON and OFF pathways 
is yet to be fully delineated. One attractive hypothesis is that the retrainment or removal 
of a dendrite is regulated by NMDA receptors. Activity strengthens synaptic contacts 
that fire synchronously and eliminates the ones firing asynchronously. The 
developmental shift of predominant NA1/NA2B receptors to more NA1/NA2A receptors 
may be a key player in this mechanism. The downstream cascade of NMDAA activation 
is yet to be clarified for this process. One possible direction is to investigate whether 
CPEBs playa role following NMDAA activation. The expression of NA2A subunit is age-
dependent and is decreased in dark-reared developing retina (Xue and Cooper 2001). 
Our study demonstrated that CPEB1, CPEB3 and CPEB4 have a similar age-dependent 
up-regulation in the retina. Whether the up-regulation/activation of CPEBs is dependent 
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on NMDAR activity could be determined in the future with the aid of the visual 
deprivation model. Agonists or antagonists of the glutamate receptors can also be 
applied in vivo. Synaptic enrichments of potential targets of CPEBs, such as CaMKIl for 
CPEB1 and GluR2 for CPEB3, can also be studied in this scenario. The causal 
relationship is still in question: Is CPEB up-regulation driven by the process of synaptic 
maturation or vice versa? 
6. Synaptic plasticity in the adult retina 
Both our real-time PCR data and Western blot data indicated that CPEB1 and CPEB3, 
and CPEB4 continue to increase after synaptogenesis and synaptic maturation, and 
reaches a plateau in adulthood (P60). This suggested CPEBs are functional in the adult 
retina. This may be related to certain forms of synaptic plasticity in the adult life. 
Neuronal plasticity has been historically characterized as a feature of the developing 
central nervous system, but there is an increasing amount of evidence which indicates 
that activity-dependent synaptic plasticity can occur both during development and 
adulthood. One form of activity dependent plasticity in the adult retina is regulated in the 
course of normal diurnallightldark cycle. GluR2-containing AM PAR undergoes rapid 
cycling in the retinal ganglion cells and amacrine cells via endocytosis and exocytosis 
(Xia et al. 2006). Synaptic quiescence in darkness drives rapid cycling which leads to 
AMPARs altering from GluR2-containing to GluR2-lacking on synaptic membrane. On 
the contrary, synaptic activity in the light inhibits cycling and stabilizes AMPAR as 
predominantly GluR2-containing on the surface. The activation of AM PARs is critical for 
the switching between cycling and non-cycling states (Xia et al. 2007). The relationship 
between AMPAR cycling and synaptic function is not well understood, but is believed to 
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have a role in certain forms of synaptic plasticity. Such cycling of AMPAR is present in 
hippocampus neurons as well, and is regulated by NMDAR activation and calcium influx 
(Biou et al. 2008). The cycling of GluR2-containing AMPARs plays a critical role in 
synaptic plasticity in the adult hippocampus (Luscher et al. 1999). 
The expression of BDNF in the retina undergoes diurnal cycles under normal light/dark 
conditions. The level of BDNF is higher during the light than during the dark (Pollock et 
al. 2001, Cooper et al. 2008). BDNFlTrkB pathway has been proposed as a mediator in 
activity-dependent plasticity. BDNF can be retrogradely transported and act as a 
regulator of the bi-directional synaptic communication (An et al. 2008; Bramham and 
Messaoudi 2005; Carvalho et al. 2008; Cohen-Cory and Lorn 2004; Tongiorgi et al. 1996; 
Tongiorgi et al. 2006). Under diurnal conditions BDNF may modulate the efficacy and 
stability of synaptic connections in visual circuits. Since BDNF has CPE and PAS motifs 
in its 3' UTR, the role of CPEBs in the regulation of BDNF during the light/dark cycles 
can be further explored using the diurnal model. 
Increasing evidence demonstrates that the outer plexiform layer of adult retina also 
possesses some degree of synaptic plasticity. For example, ectopic dendrites grow to 
make new connections in the outer plexiform layer in diseased or ageing retina (Eliasieh 
et al. 2007; Sullivan et al. 2007). Such newly formed synapses are functional and 
capable of releasing neurotransmitters. Whether CPEB3, which demonstrated strong 
labeling in the OPL of the adult retina, is involved in such remodeling is a topic worth 
pursuing in the future. 
It is conceivable that some "consensus" molecules may be involved in synaptic plasticity 
in both development and adulthood. Whether synaptic molecules such as GluR2 and 
CaMKlla work together with CPEBs in synaptic plasticity in the adult retina is a question 
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also worth pursuing. It is likely that different members of the CPEB family, or even 
different isoforms of the same paralog, are involved in distinct forms of synaptic plasticity 
or in different stages of development. 
7. Multiple CPEB3 isoforms in the retina suggest a level of complexity for CPEB3 
activity 
1) Multiple CPEB3 protein isoforms are present in the retina. 
A previous study from Kandel's group identified two alternative splicing regions of 
CPEB3 (Theis et al. 2003), which accordingly give rise to four different isoforms of 
protein (isoform 1-4 in figure 29). In the current study, we identified a total of eight 
variants of CPEB3 transcripts and seven isoforms of CPEB3 protein in the database 
(figure 28, 29). Additionally, we reported for the first time a novel isoform of CPEB3 
(figure 30c, "exon 11 missing"). 
Data derived from CPEB3 Western blots in the current study demonstrated a band as 
-75kD (figure 35c) in the retina. This band may represent one or more of CPEB3 
isoform 1-4, of which the predicted size is 78kD, 77kD, 75.5kD and 74.5kD, respectively 
(figure 29). The composition of the -75kD band could be further analyzed in future 
studies with techniques such as mass spectrometry (MS). 
Results from CPEB3 Western blots demonstrated that besides the -75kD band, there 
were two prominent bands around 130kD, one of which was absent when the antibody 
was pre-absorbed with CPEB3-recombinant protein. Of interest, the intensity of this 
band decreased during development of the retina. The -130kD band may be a dimer, a 
pre-protein, or a prion form. Each theory would explain the decrease in the relative 
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amount of the -130kD band and the corresponding increase of the 75kD band. 
However, this band was not weakened under reducing and denaturing conditions 
(adding OTT or j3-ME and the samples boiled, data not shown), where S-S disulphate 
bands, if any, should be opened up. Therefore, it seems unlikely for this band to be a 
dimer of CPEB3. The speculation that it is a pre-CPEB3 needs further evidence. It 
could be investigated with the aid of Northern blots to determine whether a larger mRNA 
corresponding to this protein is present. It can also be addressed with the aid of 
immunoprecipitation and MS if sufficient amount of protein can be obtained. Another 
speculation is that -130kD is a prion form of CPEB3. Mouse CPEB3 shares unique 
characteristics with its Ap/ysia homolog (ApCPEB): a poly-glutamine track at the N-
terminus (figure 27). This short motif confers on several proteins, including the ApCPEB, 
the structure flexibility to form prion (Darnell 2003; Si et al. 2003b; Olson 2005). Further 
stUdy with the aid of mutations or chimera proteins could be used to address whether the 
-130kD band is the prion form of CPEB3 in the mouse retina. 
Two bands smaller than 75kD (figure 35c, 67kD and 62kD, respectively) in our Western 
blots also disappeared when the antibody was pre-absorbed with the recombinant 
CPEB3. These two bands could be possible cleavage products from the -75kD band or 
the 130kD band. It is also possible that they are two different isoforms of CPEB3, since 
their sizes are consistent with that of isoform 7 and isoform 5, respectively (figure 29). 
Likewise their identities can be determined with mass spectrometry if sufficient material 
can be isolated from the retina. 
Quantification of Western blots on CPEB3 demonstrated that the level of CPEB3 protein 
(the 75kD band) was significant up-regulated from age P1 and P7 to P12. This is 
consistent with the change of CPEB3 mRNA levels during development. It is also in 
accordance with in situ hybridization results at different ages (data not shown). 
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Synaptogenesis in the mouse retina occurs prominently before eye-opening. This 
prompted a likely correlation between the function of CPEB3 and synaptogenesis in the 
retina. It would be very interesting to look into the substrate mRNAs that are regulated 
by CPEB3 with regard to whether they are components for the construction of synapses. 
One of the factors now known to be regulated by CPEB3 in is GluR2 (Huang et al. 2006), 
which is implicated in basic synaptic transmission in the hippocampus (Meng et al. 2003). 
2) CPEB3 variants provide for a higher level of regulation complexity than has been 
hitherto recognized. 
The large number of variants in the coding region, together with variability in the 5' UTR, 
and 3' UTRs of CPEB3 provides evidence for an unexpected level of complexity in 
regulatory and functional properties of CPEB3. First of all, the differences in its protein 
sequences (resulting from alternative splicing in coding exons) may involve the 
attachment of discrete "tags" to protein isoforms so that they may function in different 
temporal and spatial patterns, possibly on different RNA targets, with different protein 
partners, or upon different stimuli. Activation, inhibition or even turnover could also be 
affected by the affinity for different kinases, phosphatases, endopeptidases. Secondly, 
the regulatory and functional properties can result from the differences in the 5' UTR and 
3' UTR regions of the CPEB3 mRNAs. The UTRs may harbor signal motifs for localizing 
mRNAs to different sub-cellular compartments, subjecting the mRNA to distinct 
translation mechanisms, or degrading the mRNA via discrete pathways. One striking 
phenomenon is the presence of CPE motifs in the 3' UTR of CPEB3 mRNA, which casts 
CPEB3 mRNA as a good candidate target for CPEB1 protein. 
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8. Comparison of CPEB1 and CPEB3: 
1) CPEB1 and CPEB3 have different distribution patterns in the retina 
Our study in the retina revealed different patterns of CPEB1 and CPEB3. First, in the 
RGC layers, CPEB3 is strongly expressed in the majority of the cell soma; while CPEB 1 
in expressed in a few cell soma. Secondly, both are strongly expressed in the INL. But 
CPEB1 demonstrated laminar structures. At least two layers are distinguishable in the 
IPL. In comparison, the pattern of CPEB3 in the IPL is more diffuse. Last, labeling in 
the OPL was strong for CPEB3, but barely detectable for CPEB1. 
2) CPEB1 and CPEB3 may play different roles in the retina 
The comparision between the expression patterns of CPEB1 and CPEB3 suggested that 
CPEB1 and CPEB3 may have different roles in the retina. Different distribution for 
CPEB1 and CPEB3 has been shown in the hippocampus, where CPEB3, but not 
CPEB1 was responsive to kainate acid induced seizure (Theis et al. 2003). Protein-RNA 
binding assays revealed that CPEB1 and CPEB3 recognize different subset of mRNA 
targets (Huang et al. 2006). Although postnatal development seemed to regulate the 
expression of both, CPEB1 and CPEB3 may respond to different types of stimuli in the 
retina. Other experimental paradigms such as light! dark cycles, dark-rearing, or injury/ 
aging models may be used to further differentiate the two. 
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3) There may exist a feedback loop between CPEB1 and CPEB3 
One intriguing property of CPEB3 is that its mRNA contains two CPE motifs in the 3' 
UTR. This casts CPEB3 as a good candidate for CPEB1-regulated translational control. 
Should this be indeed the case, CPEB3 may provide a feedback loop for CPEB1 
activation. It could be a positive feedback which augments and expedites the effect of 
CPEB1 activation; or a negative feedback that eases the effect of CPEB1 activation. 
In summary, our data described the expression patterns of four CPEBs in the retina. 
There were some similarities and discrepancies between the four, both spatially and 
temporally. The function of each CPEB in the retina is yet to be delineated. It is possible 
that some degree of functional compensation of redundancy exists between certain 
CPEBs. Based on the prevalent studies on CPEB1, which have been devoted to the 
region of hippocampus in the CNS, we speculate that CPEB1 and the other CPEB 
paralogs are involved in synaptic activity, possibly synaptogenesis and certain forms of 
synaptic plasticity in the retina. A variety of congenital or acquired conditions are the 
leading causes of retinal degeneration that leads to blindness. Current knowledge about 
the capacity for remodeling and restoration of the retina is of key significance for 
developing cures for degenerative retinal diseases. The exploration of the roles of 
CPEBs and their relative abilities to regulate protein translation in the retina will advance 





Although some functional studies have been pursued for CPEB1, and to a less extent, 
for CPEB3, in the hippocampus and visual cortex, little is known with regard to the 
function of each CPEB in the retina. Some aspects of the function may be investigated 
with recapitulation of available techniques used in the other systems, in some current 
established in vitro or in vivo models. 
1. In vitro studies: Identification of mRNA targets for each CPEB. 
One of the important aspects regarding the functions of CPEB 1-4 is the substrate 
specificity of each: the mRNA targets they recognize and mediate. Our study identified 
some potential mRNA targets for CPEB1. Additionally, potential targets of CPEB2-4 
may be identified more extensively using the following approach 1). The interaction 
between the mRNA targets and individual CPEB proteins can be further validated using 
the following experiments 2) and 3). 
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1) SELEX screening in combination with bioinformatic tools 
Huang and colleagues used SELEX (systematic evolution of ligands by exponential 
enrichment) method to determine that the recognition of CPEB3 of its target mRNAs 
requires a secondary structure in the 3' UTR of the mRNA (Huang et al. 2006). A pool 
of random 2S-mer RNAs was generated from an oligonucleotide library composed of 
random 2S-mers flanked by constant regions for PCR. The RBD (RNA binding domain) 
of CPEB3 or CPEB4 were mixed with the mixed RNA pool. However, in the experiment 
followed, they found that the 3' flanking sequence is critical for the formation of the 
secondary structure during the recognition of CPEB3. Since the 3' flanking sequence 
used in their experiment was a constant sequence which was arbitrary by nature, the 
sequence of the recognition motif derived from their experiment may be limited. 
A modified version of this experiment can be performed with the following modification: 
Generate a pool of random SO-mer RNAs from an oligonucleotide library composed of 
random SO-mers flanked by constant regions for PCR. Use the pool of 50-mer RNA in 
the binding assays. ("SO" is derived from: the length of the previous 2S-mer plus the 
length of the 3' flanking sequence). Follow the same procedures for the rest of the 
experiment. 
This modification of the SELEX experiment is more inclusive and is likely to generate 
more variants of the recognition motif for the CPEB tested. Then extend from "CPE 
Detector" program, these variants can be screened in 3' UTR databases, and potential 
mRNA targets can be extracted computationally from the database. Promising mRNA 
candidates can be validated experimentally using the following in vitro binding assays or 
in cell knockdown/over-expression analysis. 
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2) In vitro binding assays 
Partial mRNAs of interest (with the 3' UTR) can be in vitro transcribed from PCR 
products using T7 promoters and radioactively labeled. Protein of interest (CPEB 1-4) 
can be expressed as recombinant protein and then refolded to natural conformation if 
necessary, or purified from tissue as biologically active form using immunoprecipitation. 
The enriched RNA probes can then be incubated with specific protein. The RNA:protein 
complex can then be subjected to gel shift assay using PAGE gel. The presence or 
absence of binding can be verified by the shift or no-shift of the band from the free probe 
band. Synthesized mRNA fragments without binding sites for CPEBs can be used as a 
negative control to account for non-specific binding. 
The in vitro binding assay can also be used in large scale screening from a biological 
sample. For example, total mRNA from the retina can be applied in incubation with 
CPEB proteins. The binding complex will then be washed, and the mRNA targets eluted 
and extracted. The identity of the mRNAs can be identified using microarray. 
3) In cell knockdown/over-expression analysis 
Cell knockdown or over-expression assay is another alternative to identify mRNAs 
associated with the CPEB. CPEB1 acts as a translational suppressor when inactivated, 
and an activator when activated, and the binding of CPEB1 to the mRNA is constitutive. 
This is also true for CPEB3 with respect to its interaction with GluR2. Therefore, a 
change in the translational levels of the target mRNAs should be detectable regardless 
of the stimulus (down-regulation without stimulus, up-regulation with appropriate 
stimulus). 
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For potential candidates, for example, from SELEX screening in combination with 
bioinformatic tools, candidate proteins can be validated using quantitative assays such 
as Western blot. Expected alterations in the level of proteins would be a strong indicator 
of the association of the mRNA with CPEB. However, verification of the physical binding 
of the two is still desirable. 
The total protein extraction from CPEB knockdown/over-expression samples can also be 
used in high-throughput analysis such as proteomics. The identity of down-regulated 
proteins (in the absence of stimulus) or up-regulated proteins (in the presence of an 
appropriate stimulus) can be verified with the protein extraction from na"lve cells as a 
control. 
2. In vivo studies 
In vivo studies should be the eventual goal to delineate the role of CPEB in the retina. 
Since it is highly likely that different CPEBs recognize discrete mRNA substrates and 
may be responsive to distinct stimuli, it is critical that appropriate models are used. 
Some experimental paradigms can be tested as discussed below: 
1) Diurnal cycle model 
As described in previous literature, GluR2-containing AMPAR undergoes rapid cycling in 
ON ganglion cells under normallightldark cycles (Xia et al. 2007; Xia et al. 2006). The 
rapid cycling of AMPARs is believed to maintain synaptic transmission and may be 
related to several forms of synaptic plasticity. Light adaptation stabilizes it in a non-
trafficking state, while dark adaptation switches it into a state of rapid cycling. The 
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activation of AMPAR is critical for the switch (Xia et al. 2006), however the underlying 
mechanism is yet to be discovered. 
GluR2 is believed to be a target of CPEB3 in the hippocampus (Huang et al 2006). 
However, whether CPEB3 mediates the translation of GluR2, or indirectly leads to the 
activation of AMPAR in the retina, is a question yet to be addressed. The diurnal model 
may serve as one diagram to explore this issue. siRNA of CPEB3 can be delivered to 
retinal ganglion cells via intravitreal injection. The expression of GluR2 or the cycling 
pattern of GluR2-containing AMPAR can then be determined. 
2) Developmental model 
The inner retina undergoes profound maturational remodeling during post-natal 
development. Such process has been proven to be activity-dependent. Our study 
demonstrated that CPEB1, 3 and 4 were up-regulated during development. CPEB1 and 
CPEB3 demonstrated a different spatial pattern. It is not known whether the expression 
of one or more CPEBs is activity dependent. Dark-rearing can be used during 
development to investigate this question. Both the spatial localization of the CPEBs and 
the quantitative level of CPEBs should be observed in dark-reared animals and in 
normal-reared control. 
3) Knockout mouse model 
CPEB 1 knockout mice may be used in comparison to normal littermates for the 
polyadenylation and translation of target mRNAs. Similarly, CPEB3 knockout mice can 
be generated; the translation of known or potential mRNA targets of CPEB3 can be 
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evaluated. Immunohistochemistry can be used to determine affected areas/cell types of 
the retina. Electrophysiology properties such as ERG, OPs, and EPSPs can be 
measured to infer the effects of CPEB knockout on the functioning of the retina. 
Behavior studies can be designed, if plausible, to elaluate the overall performance of 
vision. 
4) Photoreceptor degeneration models 
The outer plexiform layer of the retina manifested a certain degree of plasticity in mutant, 
diseases or aging that cause photoreceptor degeneration. Following the loss of synaptic 
contacts in the outer plexiform layer, horizontal cells and bipolar cells in the inner nuclear 
cells outgrow dendrites to the outer nuclear layer to form new connections with 
photoreceptors. CPEB3 appeared to be present at the outer plexiform layer in the adult 
mice (P60). The localization of CPEB3 with respect to pre-synaptic or post-synaptic 
compartment needs to be further addressed. The expression pattern of CPEB3 can be 
explored in the above models, which may provide some insights for its function in the 
outer plexiform layer. 
5) Application of kinase inhibitors, neurotransmitter agonists or antagonists 
Four CPEBs may be responsive to different stimuli. For example, CPEB3 and CPEB4, 
but not CPEB1, were up-regulated in kainate induced seizure in the hippocampus 
(Huang et al. 2006). With the appropriate stimulus, the cascade of the activation of each 
CPEB can be further delineated. CPEB1 is known to be activated by aurora kinase or 
CaMKII, both of which require the activation of NMDA receptors. Sequence analysis 
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indicated that CPEB2-4 do not possess phosphorylation site for aurora kinase, but 
appear to be substrates for PKA, CaMKIl and p70S6 kinase. Inhibitors of these kinases 
can be used to verify the cascade of phosphorylation under appropriate stimulus. 
Agonists or antagonists of different types of neurotransmitter receptors can also be 
applied to infer the requirement for the activation of receptors for each CPEB. 
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APPENDIX: LIST OF ABBREVIATIONS 
AMPA receptor binding protein 
2-amino-4-phosphonobutyrate 
Ap/ysia CPEB 
age-related macular degeneration 
a-amino-3-hydroxy-5-methyl-4-isoxazole propionate 
a-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor 
anterior-posterior 
Bacterial Protein Extraction Buffer 
Cornu Ammonis area 1 
Cornu Ammonis area 3 
choline acetyl transferase 
Brain-derived neurotrophic factor 
Ca2+/calmodulin-dependent protein kinases 
multifunctional Ca2+/calmodulin-dependent protein kinases 
multifunctional Ca2+/calmodulin-dependent protein kinases, a chain 
multifunctional Ca2+/calmodulin-dependent protein kinases, a chain 
isoformB 
cytoplasmic polyadenylation element 
cytoplasmic polyadenylation element binding protein 




























Polyadenylation Specific Factor 
dorsal-ventral 
electroretinogram 
eukaryotic translational initiation factor 4E 
eukaryotic translational initiation factor 4G 
early growth response factor-1 
a potassium channel 
extracellular signal-regulated kinase 
excitatory post synaptic potential 
6-carboxyfluorescein 
Fragile-X Mental Retardation Proteins 
gamma-aminobutyric acid 
guanine exchange factor 
AMPA medated glutamate receptor subunit 1-4 
kainate receptor subunit 1-3 
Glutamate receptor, ionotropic, AMPA mediated, subunit 1-4 
Glutamate receptor, ionotropic, NMDA mediated, subunit 1-3 
Glutamate receptor, ionotropic, kainate mediated, subunit 1-5 
glutathionine S-transferase 
Institutional Animal Care and Use Committee 
ionotropic glutamate receptors 
inner nuclear layer 
inner plexiform layer 
isopropyl ~-D-1-thiogalactopyranoside 
interstitial retinol binding protein 





























ligation-mediated polyadenylation test 
long-term depression 
long-term potentiation 
microtubule-associated protein 1 a 
microtubule-associated protein 2 
mitogen-activated protein kinase 
MAP kinase kinase 
MAP kinase kinase kinase 
MAP/ERK kinase 
mossy fiber (of hippocampus) 
metabotropic glutamate receptor 
metabotropic glutamate receptor subunit 1-5 
N-methyl-D-aspartate 
N-methyl-D-aspartate receptor 
NMDA receptor subunit 1-3 
NMDA receptor subunit 2, isoformA, B 
outer nuclear layer 
oscillatory potentials 
outer plexiform layer 
poly(A) binding protein 






























Protein Interacting with C-Kinase 1 
protein kinase A 
protein kinase C 
protein phosphatase 2, regulatory domain 1 a 
protein phosphatase 2, regulatory domain 2b 
the unprocessed pro-form of BDNF 
post synaptic density 
Polyvinylidene Fluoride 
rapid amplification of cDNA ends 
RNA binding domain 
rat ,Qalmodulin 
rod-ablated model 
retinal ganglion cell layer 
rapid amplification of cDNA ends 
retinal pigment epithelium 
reverse transcription 
RNA recognition motif 
sodium dodecyl sulfate 
systermatic evolution of ligands by exponential enrichment 
small interference RNA 
synaptic Ras-GTPase activating protein 
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